Back to Journals » Cancer Management and Research

Cancer Management and Research


Journal Articles:

- 782 records -

Long noncoding RNA ROR as a novel biomarker for progress and prognosis outcome in human cancer: a meta-analysis in the Asian population

Yang S, Chen J, Yu Y, Li D, Huang M, Yuan L, Yin G

Cancer Management and Research 2018, 10:4641-4652

Published Date: 15 October 2018

Advances in antitumor effects of NSAIDs

Zhang Z, Chen FL, Shang L

Cancer Management and Research 2018, 10:4631-4640

Published Date: 15 October 2018

CAV3.1 knockdown suppresses cell proliferation, migration and invasion of prostate cancer cells by inhibiting AKT

Hu SB, Li L, Huang W, Liu J, Lan G, Yu S, Peng L, Xie X, Yang L, Nian Y, Wang Y

Cancer Management and Research 2018, 10:4603-4614

Published Date: 15 October 2018

MicroRNA-365 suppresses cell growth and invasion in esophageal squamous cell carcinoma by modulating phosphoserine aminotransferase 1

Sun C, Zhang X, Chen Y, Jia Q, Yang J, Shu Y

Cancer Management and Research 2018, 10:4581-4590

Published Date: 15 October 2018

Moderating effects of sleep duration on diabetes risk among cancer survivors: analysis of the National Health Interview Survey in the USA

Seixas AA, Gyamfi L, Newsome V, Ranger-Murdock G, Butler M, Rosenthal DM, Zizi F, Youssef I, McFarlane SI, Jean-Louis G

Cancer Management and Research 2018, 10:4575-4580

Published Date: 12 October 2018

Castleman’s disease in the HIV-endemic setting

Mahroug E, Sher-Locketz C, Desmirean M, Abayomi EA, Tomuleasa C, Grewal R

Cancer Management and Research 2018, 10:4553-4563

Published Date: 12 October 2018

Rasip1 is a RUNX1 target gene and promotes migration of NSCLC cells

Chen Y, Zhang L, Liu L, Sun S, Zhao X, Wang Y, Zhang Y, Du J, Gu L

Cancer Management and Research 2018, 10:4537-4552

Published Date: 12 October 2018

Trends in clinical features and survival of oral cavity cancer: fifty years of experience with 3,362 consecutive cases from a single institution

Chen SW, Zhang Q, Guo ZM, Chen WK, Liu WW, Chen YF, Li QL, Liu XK, Li H, Ou-Yang D, Chen WC, Fu XY, Wang XD, Yang AK, Bei JX, Song M

Cancer Management and Research 2018, 10:4523-4535

Published Date: 12 October 2018

Severe toxicity to capecitabine due to a new variant at a donor splicing site in the dihydropyrimidine dehydrogenase (DPYD) gene

García-González X, López-Tarruella S, García MI, González-Haba E, Blanco C, Salvador-Martin S, Jerez Y, Thomas F, Jarama M, Sanjurjo Sáez M, Martín M, López-Fernández LA

Cancer Management and Research 2018, 10:4517-4522

Published Date: 11 October 2018

Clinicopathologic characteristics and clinical outcomes of pure type and mixed type of tubular carcinoma of the breast: a single-institution cohort study

Zhang WW, Wu SG, Ling YH, Sun JY, Long ZQ, Hua X, Dong Y, Li FY, He ZY, Lin HX

Cancer Management and Research 2018, 10:4509-4515

Published Date: 11 October 2018

Predictive biomarkers for tumor immune checkpoint blockade

Tong M, Wang J, He W, Wang Y, Pan H, Li D, Zhang H

Cancer Management and Research 2018, 10:4501-4507

Published Date: 11 October 2018

Prognostic values of HE4 expression in patients with cancer: a meta-analysis

Dai C, Zheng Y, Li Y, Tian T, Wang M, Xu P, Deng Y, Hao Q, Wu Y, Zhai Z, Dai Z, Lyu J

Cancer Management and Research 2018, 10:4491-4500

Published Date: 10 October 2018

Clinicopathological characteristics and survival outcomes of bladder neuroendocrine carcinomas: a population-based study

Niu Q, Lu Y, Xu S, Shi Q, Guo B, Guo Z, Huang T, Wu Y, Yu J

Cancer Management and Research 2018, 10:4479-4489

Published Date: 11 October 2018

The effect of intravenous hydration strategy on plasma methotrexate clearance during intravenous high-dose methotrexate administration in pediatric oncology patients

Traivaree C, Likasitthananon N, Monsereenusorn C, Rujkijyanont P

Cancer Management and Research 2018, 10:4471-4478

Published Date: 10 October 2018

SALL4 activates TGF-β/SMAD signaling pathway to induce EMT and promote gastric cancer metastasis

Zhang X, Zhang P, Shao M, Zang X, Zhang J, Mao F, Qian H, Xu W

Cancer Management and Research 2018, 10:4459-4470

Published Date: 10 October 2018

Confirmed value of shear wave elastography for ultrasound characterization of breast masses using a conservative approach in Chinese women: a large-size prospective multicenter trial

Lin X, Chang C, Wu CJ, Chen Q, Peng YL, Luo BM, Tang LN, Li J, Zheng JH, Zhou RH, Cui GH, Li A, Wang XM, Qian LX, Zhang JX, Wen CY, Gay J, Zhang HL, Li AH, Chen YL

Cancer Management and Research 2018, 10:4447-4458

Published Date: 11 October 2018

LINE-1 ORF-1p enhances the transcription factor activity of pregnenolone X receptor and promotes sorafenib resistance in hepatocellular carcinoma cells

Chen Y, Zeng Q, Liu X, Fu J, Zeng Z, Zhao Z, Liu Z, Bai W, Dong Z, Liu H, Lu X, Zhu Y, Lu Y

Cancer Management and Research 2018, 10:4421-4438

Published Date: 10 October 2018

Clinicopathological characteristics and prognostic factors for primary thyroid lymphoma: report on 28 Chinese patients and results of a population-based study

Chen E, Wu Q, Jin Y, Jin W, Cai Y, Wang Q, Zhang X, Wang O, Li Q, Zheng Z

Cancer Management and Research 2018, 10:4411-4419

Published Date: 10 October 2018

Importance of tumor size at diagnosis as a prognostic factor for hepatocellular carcinoma survival: a population-based study

Wu GY, Wu J, Wang BH, Zhu XL, Shi XL, Ding YT

Cancer Management and Research 2018, 10:4401-4410

Published Date: 10 October 2018

Serum miR-4530 sensitizes breast cancer to neoadjuvant chemotherapy by suppressing RUNX2

Wang XX, Ye FG, Zhang J, Li JJ, Chen QX, Lin PY, Song CG

Cancer Management and Research 2018, 10:4393-4400

Published Date: 9 October 2018

Clinicopathological characteristics and treatment outcomes of occult breast cancer: a SEER population-based study

Ge LP, Liu XY, Xiao Y, Gou ZC, Zhao S, Jiang YZ, Di GH

Cancer Management and Research 2018, 10:4381-4391

Published Date: 9 October 2018

The high pCR rate of sandwich neoadjuvant treatment in locally advanced rectal cancer may translate into a better long-term survival benefit: 5-year outcome of a Phase II clinical trial

Hu YH, Wei JW, Chang H, Xiao WW, Lin JZ, Cai MY, Cai PQ, Kong LH, Chen G, Pan ZZ, Zeng ZF, Ding PR, Gao YH

Cancer Management and Research 2018, 10:4363-4369

Published Date: 10 October 2018

LIMD1 is a survival prognostic marker of gastric cancer and hinders tumor progression by suppressing activation of YAP1

Zhang D, Li S, Yu W, Chen C, Liu T, Sun Y, Zhao Z, Liu L

Cancer Management and Research 2018, 10:4349-4361

Published Date: 9 October 2018

Application of fluorescein sodium in breast cancer brain-metastasis surgery

Xiao S, Zhang J, Zhu Z, Li Y, Zhong W, Chen J, Pan Z, Xia H

Cancer Management and Research 2018, 10:4325-4331

Published Date: 12 October 2018

Molecular characterization of papillary thyroid carcinoma: a potential three-lncRNA prognostic signature

You X, Yang S, Sui J, Wu W, Liu T, Xu S, Cheng Y, Kong X, Liang G, Yao Y

Cancer Management and Research 2018, 10:4297-4310

Published Date: 8 October 2018

Identification of genes and analysis of prognostic values in nonsmoking females with non-small cell lung carcinoma by bioinformatics analyses

Yang GD, Chen QY, Xiao JM, Zhang HL, Wang ZC, Lin XG

Cancer Management and Research 2018, 10:4287-4295

Published Date: 8 October 2018

Clinical significance of prognostic score based on age, tumor size, and grade in gastric cancer after gastrectomy

Lu J, Chen Y, Liu Y, Ding J, Piao Z, Liu W

Cancer Management and Research 2018, 10:4279-4286

Published Date: 8 October 2018

Abnormal microRNA expression in the course of hematological malignancies

Szymczyk A, Macheta A, Podhorecka M

Cancer Management and Research 2018, 10:4267-4277

Published Date: 8 October 2018

lncRNA LOC100132354 promotes angiogenesis through VEGFA/VEGFR2 signaling pathway in lung adenocarcinoma

Wang Y, Zhang F, Wang J, Hu L, Jiang F, Chen J, Chen J, Wang L

Cancer Management and Research 2018, 10:4257-4266

Published Date: 5 October 2018

Risk factors for delayed chemotherapy-induced nausea and vomiting with low-emetic-risk chemotherapy: a prospective, observational, multicenter study

Hayashi T, Shimokawa M, Matsuo K, Miyoshi T, Toriyama Y, Yokota C, Taniguchi J, Hanada K, Tsumagari K, Okubo N, Koutake Y, Sakata K, Kawamata Y, Goto T, Tsurusaki Y, Koyabu M

Cancer Management and Research 2018, 10:4249-4255

Published Date: 4 October 2018

Capsaicin-induced TRIB3 upregulation promotes apoptosis in cancer cells

Lin RJ, Wu IJ, Hong JY, Liu BH, Liang RY, Yuan TM, Chuang SM

Cancer Management and Research 2018, 10:4237-4248

Published Date: 4 October 2018

Survival and recurrence patterns of multifocal glioblastoma after radiation therapy

Syed M, Liermann J, Verma V, Bernhardt D, Bougatf N, Paul A, Rieken S, Debus J, Adeberg S

Cancer Management and Research 2018, 10:4229-4235

Published Date: 4 October 2018

IL-17 induces macrophages to M2-like phenotype via NF-κB

Shen J, Sun X, Pan B, Cao S, Cao J, Che D, Liu F, Zhang S, Yu Y

Cancer Management and Research 2018, 10:4217-4228

Published Date: 4 October 2018

Prognostic factors for postoperative survival among patients with rhabdomyosarcoma of the limbs

Ren S, Wang Z, Huang X, Sun L, Shao J, Ye Z

Cancer Management and Research 2018, 10:4181-4189

Published Date: 3 October 2018

Expression of GP88 (progranulin) in serum of prostate cancer patients is associated with Gleason scores and overall survival

Greither T, Fischer K, Theil G, Marcou M, Holzhausen HJ, Weigelt K, Serrero G, Hicks D, Yue BB, Fornara P, Wullich B, Taubert H, Wach S, Lieb V

Cancer Management and Research 2018, 10:4173-4180

Published Date: 5 October 2018

MTHFR C677T and A1298C polymorphisms and lung cancer risk in a female Chinese population

Tong W, Tong G, Jin D, Lv Q

Cancer Management and Research 2018, 10:4155-4161

Published Date: 3 October 2018

A novel gene-pair signature for relapse-free survival prediction in colon cancer

Chen P, Wang F, Zhang Z, Nie J, Liu L, Feng J, Zhou R, Wang H, Liu J, Zhao Q

Cancer Management and Research 2018, 10:4145-4153

Published Date: 3 October 2018

The role of autophagy in the radiosensitivity of the radioresistant human nasopharyngeal carcinoma cell line CNE-2R

Liang ZG, Lin GX, Yu BB, Su F, Li L, Qu S, Zhu XD

Cancer Management and Research 2018, 10:4125-4134

Published Date: 2 October 2018

Programmed death ligand 1 expression in human intrahepatic cholangiocarcinoma and its association with prognosis and CD8+ T-cell immune responses

Zhu Y, Wang XY, Zhang Y, Xu D, Dong J, Zhang Z, Yi CH, Jia HL, Yang X

Cancer Management and Research 2018, 10:4113-4123

Published Date: 2 October 2018

Locoregional recurrence-associated factors and risk-adapted postmastectomy radiotherapy for breast cancer staged in cT1-2N0-1 after neoadjuvant chemotherapy

Wang X, Xu L, Yin Z, Wang D, Wang Q, Xu K, Zhao J, Zhao L, Yuan Z, Wang P

Cancer Management and Research 2018, 10:4105-4112

Published Date: 2 October 2018

Aspirin use is associated with a reduced risk of cholangiocarcinoma: a systematic review and meta-analysis

Xiong JP, Xu WY, Bian J, Huang HC, Bai Y, Xu YY, Lu X, Zhao HT

Cancer Management and Research 2018, 10:4095-4104

Published Date: 1 October 2018

The effect of coping strategy on quality of life in patients with NSCLC

Chabowski M, Jankowska-Polanska B, Lomper K, Janczak D

Cancer Management and Research 2018, 10:4085-4093

Published Date: 1 October 2018

Dietary changes in the first 3 years after breast cancer diagnosis: a prospective Chinese breast cancer cohort study

Lei Y, Ho SC, Cheng A, Kwok C, Cheung KL, He Y, Lee CI, Lee R, Yeo W

Cancer Management and Research 2018, 10:4073-4084

Published Date: 1 October 2018

Cost-effectiveness analysis of adjuvant treatment for resected pancreatic cancer in China based on the ESPAC-4 trial

Huang J, Liao W, Zhou J, Zhang P, Wen F, Wang X, Zhang M, Zhou K, Wu Q, Li Q

Cancer Management and Research 2018, 10:4065-4072

Published Date: 1 October 2018

Progression and prognostic value of ECT2 in non-small-cell lung cancer and its correlation with PCNA

Bai X, Yi M, Xia X, Yu S, Zheng X, Wu K

Cancer Management and Research 2018, 10:4039-4050

Published Date: 28 September 2018

Role of exosomal small RNA in prostate cancer metastasis

Zhan F, Shen J, Wang R, Wang L, Dai Y, Zhang Y, Huang X

Cancer Management and Research 2018, 10:4029-4038

Published Date: 28 September 2018

EGFR-TKI-sensitive mutations in lung carcinomas: are they related to clinical features and CT findings?

Qin X, Gu X, Lu Y, Zhou W

Cancer Management and Research 2018, 10:4019-4027

Published Date: 1 October 2018

Young age is an independent adverse prognostic factor in early stage breast cancer: a population-based study

Zhang X, Yang J, Cai H, Ye Y

Cancer Management and Research 2018, 10:4005-4018

Published Date: 27 September 2018

An intronic genetic variation of MGMT affects enhancer activity and is associated with glioma susceptibility

Huang L, Xu W, Dai L, Yan D, Zhang S, Shi X

Cancer Management and Research 2018, 10:3995-4003

Published Date: 27 September 2018

Identification of WDR12 as a novel oncogene involved in hepatocellular carcinoma propagation

Yin Y, Zhou L, Zhan R, Zhang Q, Li M

Cancer Management and Research 2018, 10:3985-3993

Published Date: 27 September 2018

Benefit of adjuvant radiotherapy following narrow-margin hepatectomy in patients with intrahepatic cholangiocarcinoma that adhere to major vessels

Zheng X, Chen B, Wu JX, Jia AY, Rong WQ, Wang LM, Wu F, Zhao YT, Li YX, Wang WH

Cancer Management and Research 2018, 10:3973-3981

Published Date: 26 September 2018

Galectin-3 and β-catenin are associated with a poor prognosis in serous epithelial ovarian cancer

Liu Y, Xie L, Wang D, Li D, Xu G, Wang L, Zhou H, Yu Y, Lin Z, Lu H

Cancer Management and Research 2018, 10:3963-3971

Published Date: 26 September 2018

Villoglandular adenocarcinoma of cervix: pathologic features, clinical management, and outcome

Guo P, Liu PF, Yang JJ, Ren T, Xiang Y

Cancer Management and Research 2018, 10:3955-3961

Published Date: 26 September 2018

Difference of molecular alterations in HER2-positive and HER2-negative gastric cancers by whole-genome sequencing analysis

Zhou C, Feng X, Yuan F, Ji J, Shi M, Yu Y, Zhu Z, Zhang J

Cancer Management and Research 2018, 10:3945-3954

Published Date: 26 September 2018

KLF6-SV1 is a new prognostic biomarker in postoperative patients with non-small cell lung cancer

Zhang N, Li Z, Xiao W, Yang F, Gao W, Sun ZG

Cancer Management and Research 2018, 10:3937-3944

Published Date: 26 September 2018

Effects of controlled ovarian stimulation on toxicity of TAC chemotherapy in early breast cancer patients

de Groot S, Louwé LA, Ramautar AIE, Portielje JEA, Ogilvie AC, Batman E, Fiocco M, Kroep JR

Cancer Management and Research 2018, 10:3931-3935

Published Date: 26 September 2018

Prognostic value of the combination of microsatellite instability and BRAF mutation in colorectal cancer

Yang Y, Wang D, Jin L, Wu G, Bai Z, Wang J, Yao H, Zhang Z

Cancer Management and Research 2018, 10:3911-3929

Published Date: 26 September 2018

First-line treatment strategies for newly diagnosed chronic myeloid leukemia: a network meta-analysis

Chen KK, Du TF, Wu KS, Yang W

Cancer Management and Research 2018, 10:3891-3910

Published Date: 25 September 2018

CircZNF609 promotes breast cancer cell growth, migration, and invasion by elevating p70S6K1 via sponging miR-145-5p

Wang S, Xue X, Wang R, Li X, Li Q, Wang Y, Xie P, Kang Y, Meng R, Feng X

Cancer Management and Research 2018, 10:3881-3890

Published Date: 25 September 2018

Young age increases the risk of lymph node positivity in papillary thyroid cancer patients: a SEER data-based study

Wang J, Liu J, Pan H, Jiang C, Liu S, Zhu Z, Fang J, Zheng X, Hong S, Wang S

Cancer Management and Research 2018, 10:3867-3873

Published Date: 25 September 2018

CD44 is overexpressed and correlated with tumor progression in gallbladder cancer

He YT, Xue C, Yu Y, Chen JA, Chen XL, Ren F, Ren ZG, Cui GY, Sun RR

Cancer Management and Research 2018, 10:3857-3865

Published Date: 24 September 2018

Metabolic syndrome and the risk of cholangiocarcinoma: a hospital-based case–control study in China

Xiong J, Lu X, Xu W, Bai Y, Huang H, Bian J, Zhang L, Long J, Xu Y, Wang Z, Zhao H

Cancer Management and Research 2018, 10:3849-3855

Published Date: 24 September 2018

Multidisciplinary therapy for scirrhous gastric cancer: a retrospective analysis and proposal of new treatment strategy

Fushida S, Kinoshita J, Oyama K, Fujimura T, Tsukada T, Yamaguchi T, Ninomiya I, Ohta T

Cancer Management and Research 2018, 10:3833-3839

Published Date: 24 September 2018

Computed tomography scan efficacy in staging gastric linitis plastica lesion: a retrospective multicentric French study

Morgant S, Artru P, Oudjit A, Lourenco N, Pasquer A, Walter T, Gornet JM, Rouquette A, Lledo G, Brezault C, Coriat R

Cancer Management and Research 2018, 10:3825-3831

Published Date: 24 September 2018

Efficacy and safety of de-escalation bone-modifying agents for cancer patients with bone metastases: a systematic review and meta-analysis

Liu C, Wang L, Liu L, Zhuang J, Tang S, Zhang TS, Zhou C, Feng F, Liu R, Zhang J, Zhang T, Gao C, Li H, Li J, Sun C

Cancer Management and Research 2018, 10:3809-3823

Published Date: 21 September 2018

Secondhand smoking increases bladder cancer risk in nonsmoking population: a meta-analysis

Yan H, Ying Y, Xie H, Li J, Wang X, He L, Jin K, Tang J, Xu X, Zheng X

Cancer Management and Research 2018, 10:3781-3791

Published Date: 21 September 2018

Spotlight on cabozantinib for previously untreated advanced renal cell carcinoma: evidence to date

Bersanelli M, Leonardi F, Buti S

Cancer Management and Research 2018, 10:3773-3780

Published Date: 21 September 2018

The impact of biopsy sampling errors and the quality of surgical margins on local recurrence and survival in chondrosarcoma

Hodel S, Laux CJ, Farei-Campagna J, Götschi T, Bode-Lesniewska B, Müller DA

Cancer Management and Research 2018, 10:3765-3771

Published Date: 21 September 2018

S100A9 regulates cisplatin chemosensitivity of squamous cervical cancer cells and related mechanism

Zhao C, Lu E, Hu X, Cheng H, Zhang JA, Zhu X

Cancer Management and Research 2018, 10:3753-3764

Published Date: 20 September 2018

Emerging clinical significance of claudin-7 in colorectal cancer: a review

Wang K, Xu C, Li WJ, Ding L

Cancer Management and Research 2018, 10:3741-3752

Published Date: 20 September 2018

Stereotactic radiosurgery for vestibular schwannomas

Braunstein S, Ma L

Cancer Management and Research 2018, 10:3733-3740

Published Date: 20 September 2018

An expression signature model to predict lung adenocarcinoma-specific survival

Shi X, Tan H, Le X, Xian H, Li X, Huang K, Luo VY, Liu Y, Wu Z, Mo HY, Chen AM, Liang Y, Zhang J

Cancer Management and Research 2018, 10:3717-3732

Published Date: 24 September 2018

Low expression of VSIG4 is associated with poor prognosis in hepatocellular carcinoma patients with hepatitis B infection

Zhu S, Tan W, Li W, Zhou R, Wu X, Chen X, Li W, Shang C, Chen Y

Cancer Management and Research 2018, 10:3697-3705

Published Date: 20 September 2018

Decreased expression of TRIM21 indicates unfavorable outcome and promotes cell growth in breast cancer

Zhou WB, Zhang YY, Zhong CN, Hu JT, Hu H, Zhou DX, Cao MQ

Cancer Management and Research 2018, 10:3687-3696

Published Date: 20 September 2018

Impact of CT slice thickness on volume and dose evaluation during thoracic cancer radiotherapy

Luo H, He Y, Jin F, Yang D, Liu X, Ran X, Wang Y

Cancer Management and Research 2018, 10:3679-3686

Published Date: 20 September 2018

Gemcitabine and docetaxel as second-line chemotherapy in elderly patients with metastatic urothelial carcinoma: a retrospective analysis

Naiki T, Iida K, Etani T, Nagai T, Tanaka Y, Sugiyama Y, Ando R, Hamamoto S, Banno R, Nagata D, Kawai N, Yasui T

Cancer Management and Research 2018, 10:3669-3677

Published Date: 18 September 2018

No association between tumor laterality and cardiac-related mortality in breast cancer patients after radiotherapy: a population-based study

Li WH, Zhang ZG, Huang ZR, Zhang W, Li ZB, Qi ZQ

Cancer Management and Research 2018, 10:3649-3656

Published Date: 18 September 2018

Efficacy and safety of lenalidomide for the treatment of acute myeloid leukemia: a systematic review and meta-analysis

Xie CH, Wei M, Yang FY, Wu FZ, Chen L, Wang JK, Liu Q, Huang JX

Cancer Management and Research 2018, 10:3637-3648

Published Date: 18 September 2018

Predictive factors for the efficacy of the second taxane treatment in patients with advanced cancer

Imai H, Saijo K, Komine K, Kawamura Y, Hiraide S, Umegaki S, Okada Y, Ouchi K, Sato Y, Takahashi M, Takahashi S, Shirota H, Takahashi M, Ishioka C

Cancer Management and Research 2018, 10:3629-3636

Published Date: 17 September 2018

Development of a risk grading system to identify patients with acute promyelocytic leukemia at high risk of early death

Zhang Y, Hou W, Wang P, Hou J, Yang H, Zhao H, Jin B, Sun J, Cao F, Zhao Y, Li H, Ge F, Fu J, Zhou J

Cancer Management and Research 2018, 10:3619-3627

Published Date: 17 September 2018

Neutrophil–lymphocyte ratio is a predictor of prognosis in patients with castration-resistant prostate cancer: a meta-analysis

Wang Z, Peng S, Xie H, Guo L, Jiang N, Shang Z, Niu Y

Cancer Management and Research 2018, 10:3599-3610

Published Date: 17 September 2018

Perivascular cell coverage of intratumoral vasculature is a predictor for bevacizumab efficacy in metastatic colorectal cancer

Jiang C, Huang Y, Lu J, Yang Y, Rao H, Zhang B, He W, Xia L

Cancer Management and Research 2018, 10:3589-3597

Published Date: 17 September 2018

miR-300 rs12894467 polymorphism may be associated with susceptibility to primary lung cancer in the Chinese Han population

Liu Z, Lin Y, Kang S, Xu Q, Xiong W, Cai L, He F

Cancer Management and Research 2018, 10:3579-3588

Published Date: 17 September 2018

Low tumor purity is associated with poor prognosis, heavy mutation burden, and intense immune phenotype in colon cancer

Mao Y, Feng Q, Zheng P, Yang L, Liu T, Xu Y, Zhu D, Chang W, Ji M, Ren L, Wei Y, He G, Xu J

Cancer Management and Research 2018, 10:3569-3577

Published Date: 17 September 2018

PLNR≤20% may be a benefit from PORT for patients with IIIA-N2 NSCLC: a large population-based study

Shang X, Li Z, Lin J, Wang H, Wang Z

Cancer Management and Research 2018, 10:3561-3567

Published Date: 17 September 2018

Epidermal growth factor receptor gene mutations in non-small-cell lung cancer cells are associated with increased radiosensitivity in vitro

Xie B, Sun LY, Cheng YJ, Zhou J, Zheng JH, Zhang WM

Cancer Management and Research 2018, 10:3551-3560

Published Date: 13 September 2018

Identification of key candidate genes and small molecule drugs in cervical cancer by bioinformatics strategy

Tang X, Xu YC, Lu L, Jiao Y, Liu JJ, Wang LL, Zhao HB

Cancer Management and Research 2018, 10:3533-3549

Published Date: 13 September 2018

Expressions and prognostic values of the E2F transcription factors in human breast carcinoma

Liu ZL, Bi XW, Liu PP, Lei DX, Wang Y, Li ZM, Jiang WQ, Xia Y

Cancer Management and Research 2018, 10:3521-3532

Published Date: 13 September 2018

Enhanced recovery after surgery decreases intestinal recovery time and pain intensity in patients undergoing curative gastrectomy

Ji W, Chandoo A, Guo X, You T, Shao Z, Zheng K, Wang J, Bi J, Smith FG, Tucker ON, Shen X

Cancer Management and Research 2018, 10:3513-3520

Published Date: 13 September 2018

CD8+ tumor-infiltrating lymphocytes as a novel prognostic biomarker in lung sarcomatoid carcinoma, a rare subtype of lung cancer

Chen J, He Q, Liu J, Xiao Y, Xiao C, Chen K, Xie D, Zhang X

Cancer Management and Research 2018, 10:3505-3511

Published Date: 13 September 2018

Letter to the editor “Prognostic value of microRNAs in colorectal cancer: a meta-analysis”

Jayaraj R, Kumarasamy C, Gothandam KM

Cancer Management and Research 2018, 10:3501-3503

Published Date: 13 September 2018

Combined use of CDK4/6 and mTOR inhibitors induce synergistic growth arrest of diffuse intrinsic pontine glioma cells via mutual downregulation of mTORC1 activity

Asby DJ, Killick-Cole CL, Boulter LJ, Singleton WGB, Asby CA, Wyatt MJ, Barua NU, Bienemann AS, Gill SS

Cancer Management and Research 2018, 10:3483-3500

Published Date: 12 September 2018

Splenectomy during cytoreductive surgery in epithelial ovarian cancer

Sun H, Bi X, Cao D, Yang J, Wu M, Pan L, Huang H, Chen G, Shen K

Cancer Management and Research 2018, 10:3473-3482

Published Date: 12 September 2018

Establishment and validation of a 7-microRNA prognostic signature for non-small cell lung cancer

Wang N, Guo H, Dong Z, Chen Q, Zhang X, Shen W, Bao Y, Wang X

Cancer Management and Research 2018, 10:3463-3471

Published Date: 12 September 2018

Assessment of functional variants and expression of long noncoding RNAs in vitamin D receptor signaling in breast cancer

Kholghi Oskooei V, Geranpayeh L, Omrani MD, Ghafouri-Fard S

Cancer Management and Research 2018, 10:3451-3462

Published Date: 12 September 2018

Overexpression of kinesin family member 20A is associated with unfavorable clinical outcome and tumor progression in epithelial ovarian cancer

Li H, Zhang W, Sun X, Chen J, Li Y, Niu C, Xu B, Zhang Y

Cancer Management and Research 2018, 10:3433-3450

Published Date: 12 September 2018

Prognostic value of EGFR and KRAS in resected non-small cell lung cancer: a systematic review and meta-analysis

Zhang SM, Zhu QG, Ding XX, Lin S, Zhao J, Guan L, Li T, He B, Zhang HQ

Cancer Management and Research 2018, 10:3393-3404

Published Date: 10 September 2018

Identification of an eight-gene prognostic signature for lung adenocarcinoma

Li S, Xuan Y, Gao B, Sun X, Miao S, Lu T, Wang Y, Jiao W

Cancer Management and Research 2018, 10:3383-3392

Published Date: 10 September 2018

The correlation between microRNA-221/222 cluster overexpression and malignancy: an updated meta-analysis including 2693 patients

Zhang P, Zhang M, Han R, Zhang K, Ding H, Liang C, Zhang L

Cancer Management and Research 2018, 10:3371-3381

Published Date: 10 September 2018

RBBP6 expressional effects on cell proliferation and apoptosis in breast cancer cell lines with distinct p53 statuses

Motadi LR, Lekganyane MM, Moela P

Cancer Management and Research 2018, 10:3357-3369

Published Date: 10 September 2018

Associations of sirtuins with clinicopathological parameters and prognosis in non–small cell lung cancer

Gong J, Wang H, Lou W, Wang G, Tao H, Wen H, Liu Y, Xie Q

Cancer Management and Research 2018, 10:3341-3356

Published Date: 10 September 2018

Significance of circulating tumor cells in osteosarcoma patients treated by neoadjuvant chemotherapy and surgery

Wu ZJ, Tan JC, Qin X, Liu B, Yuan ZC

Cancer Management and Research 2018, 10:3333-3339

Published Date: 10 September 2018

Can bone scans guide therapy with radium-223 dichloride for prostate cancer bone metastases?

Gayed I, Salama V, Dawood L, Canfield S, Wan D, Cai C, Joseph U, Amato R

Cancer Management and Research 2018, 10:3317-3324

Published Date: 7 September 2018

FOXA1 is upregulated in glioma and promotes proliferation as well as cell cycle through regulation of cyclin D1 expression

Zhang C, Yang M, Li Y, Tang S, Sun X

Cancer Management and Research 2018, 10:3283-3293

Published Date: 6 September 2018

Combination of recurrent oral aphthae and dry eye syndrome may constitute an independent risk factor for oral cavity cancer in elderly women

Qin L, Kao YW, Lin YL, Peng BY, Deng WP, Chen TM, Lin KC, Yuan KSP, Wu ATH, Shia BC, Wu SY

Cancer Management and Research 2018, 10:3273-3281

Published Date: 5 September 2018

Prognostic value of minichromosome maintenance mRNA expression in early-stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy

Liao X, Han C, Wang X, Huang K, Yu T, Yang C, Huang R, Liu Z, Han Q, Peng T

Cancer Management and Research 2018, 10:3255-3271

Published Date: 5 September 2018

A novel SWIM domain protein ZSWIM5 inhibits the malignant progression of non-small-cell lung cancer

Xu K, Liu B, Ma Y, Xu B, Xing X

Cancer Management and Research 2018, 10:3245-3254

Published Date: 4 September 2018

Cervical cancer screening using the Cervista high-risk human papillomavirus test: opportunistic screening of a hospital-based population in Fujian province, China

Ruan GY, Song YY, Dong BH, Mao XD, Lin F, Kang YF, Xu SX, Chen XJ, Wu QB, Sun PM

Cancer Management and Research 2018, 10:3227-3235

Published Date: 4 September 2018

Treatment strategies and predicting prognoses in elderly patients with breast cancer

Wang Z, Zhou Z, Li W, Wang W, Xie X, Liu J, Song Y, Dang C, Zhang H

Cancer Management and Research 2018, 10:3207-3218

Published Date: 4 September 2018

Correlation of variable repeat number in the neck regions of DC-SIGN and DC-SIGNR with susceptibility to nasopharyngeal carcinoma in a Chinese population

Ning S, Yao M, Wu Y, Zhou X, Zhong C, Yan K, Wei Z, Xie Y

Cancer Management and Research 2018, 10:3193-3198

Published Date: 4 September 2018

Trend in relative survival in squamous cervical cancer by decade from 1983 to 2012: a period analysis

Wu J, Sun H, Wang S, Yan Y, Sun F, Li Y, Yang G, Ma H

Cancer Management and Research 2018, 10:3177-3191

Published Date: 3 September 2018

Prognostic value of tumor burden in nasopharyngeal carcinoma

Chen CB, Fei ZD, Huang CX, Ding JM, Chen LS

Cancer Management and Research 2018, 10:3169-3175

Published Date: 3 September 2018

ZNF259 promotes breast cancer cells invasion and migration via ERK/GSK3β/snail signaling

Liu B, Xing X, Li X, Guo Q, Xu T, Xu K

Cancer Management and Research 2018, 10:3159-3168

Published Date: 3 September 2018

Methyl jasmonate enhances the radiation sensitivity of esophageal carcinoma cells by inhibiting the 11-ketoprostaglandin reductase activity of AKR1C3

Li XY, Hong X, Gao XS, Gu XB, Xiong W, Zhao J, Yu HL, Cui M, Xie M, Bai Y, Sun SQ

Cancer Management and Research 2018, 10:3149-3158

Published Date: 31 August 2018

Association between lncRNA CASC8 polymorphisms and the risk of cancer: a meta-analysis

Cui Z, Gao M, Yin Z, Yan L, Cui L

Cancer Management and Research 2018, 10:3141-3148

Published Date: 31 August 2018

Prognostic value of serum alkaline phosphatase in the survival of prostate cancer: evidence from a meta-analysis

Li D, Lv H, Hao X, Hu B, Song Y

Cancer Management and Research 2018, 10:3125-3139

Published Date: 30 August 2018

Probe-based three-dimensional confocal laser endomicroscopy of brain tumors: technical note

Belykh E, Patel AA, Miller EJ, Bozkurt B, Yağmurlu K, Woolf EC, Scheck AC, Eschbacher JM, Nakaji P, Preul MC

Cancer Management and Research 2018, 10:3109-3123

Published Date: 30 August 2018

Clinical utility of fulvestrant in the treatment of breast cancer: a report on the emerging clinical evidence

Rocca A, Maltoni R, Bravaccini S, Donati C, Andreis D

Cancer Management and Research 2018, 10:3083-3099

Published Date: 30 August 2018

A mono-carbonyl analog of curcumin induces apoptosis in drug-resistant EGFR-mutant lung cancer through the generation of oxidative stress and mitochondrial dysfunction

Dai X, Zhang J, Guo G, Cai Y, Cui R, Yin C, Liu W, Vinothkumar R, Zhang T, Liang G, Zhang X

Cancer Management and Research 2018, 10:3069-3082

Published Date: 29 August 2018

Analysis of potential genes associated with primary cilia in bladder cancer

Du E, Lu C, Sheng F, Li C, Li H, Ding N, Chen Y, Zhang T, Yang K, Xu Y

Cancer Management and Research 2018, 10:3047-3056

Published Date: 29 August 2018

The predictive value of cumulative toxicity for quality of life in patients with metastatic colorectal cancer during first-line palliative chemotherapy

Schuurhuizen CSEW, Verheul HMW, Braamse AMJ, Buffart LM, Bloemendal HJ, Dekker J, Konings IRHM

Cancer Management and Research 2018, 10:3015-3021

Published Date: 29 August 2018

Distinct prognostic values of mRNA expression of glutathione peroxidases in non–small cell lung cancer

Liu K, Jin M, xiao L, Liu H, Wei S

Cancer Management and Research 2018, 10:2997-3005

Published Date: 28 August 2018

Elevated serum LAMC2 is associated with lymph node metastasis and predicts poor prognosis in penile squamous cell carcinoma

Zhou Q, Deng C, Chen J, Huang K, Liu T, Yao K, Liu ZW, Qin Z, Li Y, Guo S, Ye Y, Zhou F, Huang W, Liu R, Han H

Cancer Management and Research 2018, 10:2983-2995

Published Date: 28 August 2018

Treatment outcomes of ureteral stenting for malignant extrinsic ureteral obstruction: a comparison between polymeric and metallic stents

Asakawa J, Iguchi T, Tamada S, Ninomiya N, Kato M, Yamasaki T, Nakatani T

Cancer Management and Research 2018, 10:2977-2982

Published Date: 28 August 2018

Diagnostic potential of methylated DAPK in brushing samples of nasopharyngeal carcinoma

Zhang J, Shen Z, Liu H, Liu S, Shu W

Cancer Management and Research 2018, 10:2953-2964

Published Date: 28 August 2018

Incidence of bone metastasis and factors contributing to its development and prognosis in newly diagnosed renal cell carcinoma: a population-based study

Guo Q, Zhang C, Guo X, Tao F, Xu Y, Feng G, Han X, Ren Z, Zhang H, Zhang P, Wang X, Wang G

Cancer Management and Research 2018, 10:2935-2944

Published Date: 28 August 2018

TNM-PNI: a novel prognostic scoring system for patients with gastric cancer and curative D2 resection

Gao ZM, Wang RY, Deng P, Ding P, Zheng C, Hou B, Li K

Cancer Management and Research 2018, 10:2925-2933

Published Date: 28 August 2018

Efficacy and safety of TAS-102 in refractory metastatic colorectal cancer: a meta-analysis

Chen D, Wu YS, Lin H, Wang Y, Li L, Zhang T

Cancer Management and Research 2018, 10:2915-2924

Published Date: 28 August 2018

Trichostatin A promotes GLI1 degradation and P21 expression in multiple myeloma cells

Geng Y, Liu J, Xie Y, Jiang H, Zuo K, Li T, Liu Z

Cancer Management and Research 2018, 10:2905-2914

Published Date: 28 August 2018

The role of CCN4/WISP-1 in the cancerous phenotype

Nivison MP, Meier KE

Cancer Management and Research 2018, 10:2893-2903

Published Date: 27 August 2018

Long-term oncologic outcomes of papillary thyroid microcarcinoma according to the presence of clinically apparent lymph node metastasis: a large retrospective analysis of 5,348 patients

Choi JB, Lee WK, Lee SG, Ryu H, Lee CR, Kang SW, Jeong JJ, Nam KH, Lee EJ, Chung WY, Jo YS, Lee J

Cancer Management and Research 2018, 10:2883-2891

Published Date: 27 August 2018

Differences in clinical characteristics and mutational pattern between synchronous and metachronous colorectal liver metastases

Zheng P, Ren L, Feng Q, Zhu D, Chang W, He G, Ji M, Jian M, Lin Q, Yi T, Wei Y, Xu J

Cancer Management and Research 2018, 10:2871-2881

Published Date: 27 August 2018

Using LC–MS/MS-based targeted proteomics to monitor the pattern of ABC transporters expression in the development of drug resistance

Meng F, Zou L, Zhang T, Jiang L, Ding Y, Yu P, Peng J

Cancer Management and Research 2018, 10:2859-2870

Published Date: 23 August 2018

MicroRNA-200b expression level is negatively associated with pathological grading in human gliomas

Kong X, Gong S, Yan T, Yang Y

Cancer Management and Research 2018, 10:2825-2834

Published Date: 24 August 2018

Treatment options for refractory/relapsed multiple myeloma: an updated evidence synthesis by network meta-analysis

Luo XW, Du XQ, Li JL, Liu XP, Meng XY

Cancer Management and Research 2018, 10:2817-2823

Published Date: 21 August 2018

The association of HIF-1α expression with clinicopathological significance in prostate cancer: a meta-analysis

Huang M, Du H, Zhang L, Che H, Liang C

Cancer Management and Research 2018, 10:2809-2816

Published Date: 21 August 2018

LncRNA TINCR is associated with clinical progression and serves as tumor suppressive role in prostate cancer

Dong L, Ding H, Li Y, Xue D, Liu Y

Cancer Management and Research 2018, 10:2799-2807

Published Date: 20 August 2018

Prognostic value of inflammation-based prognostic index in patients with nasopharyngeal carcinoma: a propensity score matching study

Oei RW, Ye L, Kong F, Du C, Zhai R, Xu T, Shen C, Wang X, He X, Kong L, Hu C, Ying H

Cancer Management and Research 2018, 10:2785-2797

Published Date: 17 August 2018

The expression profile and clinical application potential of hsa_circ_0000711 in colorectal cancer

Li J, Ni S, Zhou C, Ye M

Cancer Management and Research 2018, 10:2777-2784

Published Date: 17 August 2018

G-CSF associates with neurogenesis and predicts prognosis and sensitivity to chemotherapy in pancreatic ductal adenocarcinoma

Zhang L, Tao L, Guo L, Zhan J, Yuan C, Ma Z, Jiang B, Xiu D

Cancer Management and Research 2018, 10:2767-2775

Published Date: 17 August 2018

High Spy1 expression predicts poor prognosis in colorectal cancer

Jin Q, Liu G, Bao L, Ma Y, Qi H, Yun Z, Dai Y, Zhang S

Cancer Management and Research 2018, 10:2757-2765

Published Date: 16 August 2018

Prevalence and characteristics of colonic adenoma in mainland China

Hong W, Dong L, Stock S, Basharat Z, Zippi M, Zhou M

Cancer Management and Research 2018, 10:2743-2755

Published Date: 16 August 2018

Low-dose eribulin mesylate exerts antitumor effects in gastric cancer by inhibiting fibrosis via the suppression of epithelial–mesenchymal transition and acts synergistically with 5-fluorouracil

Kurata T, Fushida S, Kinoshita J, Oyama K, Yamaguchi T, Okazaki M, Miyashita T, Tajima H, Ninomiya I, Ohta T

Cancer Management and Research 2018, 10:2729-2742

Published Date: 15 August 2018

lncRNA PVT1 identified as an independent biomarker for prognosis surveillance of solid tumors based on transcriptome data and meta-analysis

Chen X, Yang Y, Cao Y, Wu C, Wu S, Su Z, Jin H, Wang D, Zhang G, Fan W, Lin J, Zeng Y, Hu D

Cancer Management and Research 2018, 10:2711-2727

Published Date: 16 August 2018

A network-based signature to predict the survival of non-smoking lung adenocarcinoma

Mao Q, Zhang L, Zhang Y, Dong G, Yang Y, Xia W, Chen B, Ma W, Hu J, Jiang F, Xu L

Cancer Management and Research 2018, 10:2683-2693

Published Date: 16 August 2018

Proximal shift of colorectal cancer with increasing age in different ethnicities

Yang L, Xiong Z, He W, Xie K, Liu S, Kong P, Jiang C, Guo G, Xia L

Cancer Management and Research 2018, 10:2663-2673

Published Date: 15 August 2018

IL-17 and colorectal cancer risk in the Middle East: gene polymorphisms and expression

Al Obeed OA, Vaali-Mohammed MA, Alkhayal KA, Bin Traiki TA, Zubaidi AM, Arafah M, Harris RA, Khan Z, Abdulla MH

Cancer Management and Research 2018, 10:2653-2661

Published Date: 5 September 2018

Use of FLT3 inhibitors in acute myeloid leukemia remission induction or salvage therapy: systematic review and meta-analysis

Yang M, Zhao J, Liu T, Yang X, Wei H, Xu W, Xiao J

Cancer Management and Research 2018, 10:2635-2652

Published Date: 14 August 2018

Upregulated expression of miR-421 is associated with poor prognosis in non-small-cell lung cancer

Li Y, Cui X, Li Y, Zhang T, Li S

Cancer Management and Research 2018, 10:2627-2633

Published Date: 13 August 2018

Risk factors for gastric intraepithelial neoplasia in Chinese adults: a case–control study

Yu Y, Fang C, Peng C, Shen S, Xu G, Sun Q, Li L, Su C, Zou X

Cancer Management and Research 2018, 10:2605-2613

Published Date: 13 August 2018

Short- and long-term outcomes of laparoscopic hepatectomy for colorectal liver metastases in elderly patients

Yue M, Li S, Yan G, Li C, Kang Z

Cancer Management and Research 2018, 10:2581-2587

Published Date: 10 August 2018

Clinical value of circulating ESR1 mutations for patients with metastatic breast cancer: a meta-analysis

Zhang K, Hong R, Xu F, Xia W, Kaping L, Qin G, Zheng Q, Lu Q, Shi YX, Yuan ZY, Wang SS

Cancer Management and Research 2018, 10:2573-2580

Published Date: 14 August 2018

E2F1 induces LSINCT5 transcriptional activity and promotes gastric cancer progression by affecting the epithelial-mesenchymal transition

Qi P, Lin W, Zhang M, Huang D, Ni S, Zhu X, Bai Q, Sheng W, Du X, Zhou X

Cancer Management and Research 2018, 10:2563-2571

Published Date: 10 August 2018

The efficacy and safety of olaparib in the treatment of cancers: a meta-analysis of randomized controlled trials

Guo XX, Wu HL, Shi HY, Su L, Zhang X

Cancer Management and Research 2018, 10:2553-2562

Published Date: 10 August 2018

Genome-scale analysis to identify prognostic microRNA biomarkers in patients with early stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy

Liao X, Wang X, Huang K, Yang C, Yu T, Han C, Zhu G, Su H, Huang R, Peng T

Cancer Management and Research 2018, 10:2537-2551

Published Date: 10 August 2018

Novel endocrine therapeutic strategy in endometrial carcinoma targeting estrogen-related receptor α by XCT790 and siRNA

Sun PM, Mao XD, Gao M, Huang MM, Chen LL, Ruan GY, Huang WY, Braicu EI, Sehouli J

Cancer Management and Research 2018, 10:2521-2535

Published Date: 10 August 2018

Adjuvant chemotherapy for stage II colon cancer: who really needs it

Yang Y, Yang Y, Yang H, Wang F, Wang HH, Chen Q, Liu Y, Li AY, Zhang QA

Cancer Management and Research 2018, 10:2509-2520

Published Date: 8 August 2018

Association of low skeletal muscle index with increased systematic inflammatory responses and interferon γ-induced protein 10 levels in patients with colon cancer

He WZ, Yang QX, Xie JY, Kong PF, Hu WM, Yang L, Yang YZ, Xie QK, Jiang C, Yin CX, Guo GF, Qiu HJ, Zhang B, Xia LP

Cancer Management and Research 2018, 10:2499-2507

Published Date: 7 August 2018

Biological and clinical influences of NPM1 in acute myeloid leukemia patients with DNMT3A mutations

Yang X, Shi J, Zhang X, Zhang G, Zhang J, Yang S, Wang J, Ke X, Fu L

Cancer Management and Research 2018, 10:2489-2497

Published Date: 7 August 2018

Bone metastasis predicts poor prognosis of patients with brain metastases from colorectal carcinoma post aggressive treatment

Duan H, He ZQ, Guo CC, Li JH, Wang J, Zhu Z, Sai K, Chen ZP, Jiang XB, Mou YG

Cancer Management and Research 2018, 10:2467-2474

Published Date: 6 August 2018

Clinical and biological implications of IDH1/2 in acute myeloid leukemia with DNMT3Amut

Zhang XP, Shi JL, Zhang JL, Yang XR, Zhang GQ, Yang SY, Wang J, Ke XY, Fu L

Cancer Management and Research 2018, 10:2457-2466

Published Date: 6 August 2018

Model of lymph node metastasis posterior to the right recurrent laryngeal nerve in papillary thyroid carcinoma

Luo Y, Xu XC, Shen J, Shi JJ, Lu S, He W, Lei JY, Luo DC

Cancer Management and Research 2018, 10:2449-2455

Published Date: 6 August 2018

Tracking steps in oncology: the time is now

Purswani JM, Ohri N, Champ C

Cancer Management and Research 2018, 10:2439-2447

Published Date: 3 August 2018

TMEM17 promotes malignant progression of breast cancer via AKT/GSK3β signaling

Zhao Y, Song K, Zhang Y, Xu H, Zhang X, Wang L, Fan C, Jiang G, Wang E

Cancer Management and Research 2018, 10:2419-2428

Published Date: 2 August 2018

Surgical significance and efficacy of epidermal growth factor receptor tyrosine kinase inhibitors in patients with primary lung adenosquamous carcinoma

Zhang C, Yang H, Lang B, Yu X, Xiao P, Zhang D, Fan L, Zhang X

Cancer Management and Research 2018, 10:2401-2407

Published Date: 2 August 2018

LRH-1 drives hepatocellular carcinoma partially through induction of c-myc and cyclin E1, and suppression of p21

Xiao L, Wang Y, Liang W, Liu L, Pan N, Deng H, Li L, Zou C, Chan FL, Zhou Y

Cancer Management and Research 2018, 10:2389-2400

Published Date: 1 August 2018

Lack of association between the risk of prostate cancer and vitamin D receptor Bsm I polymorphism: a meta-analysis of 27 published studies

Kang S, Zhao Y, Wang L, Liu J, Chen X, Liu X, Shi Z, Gao W, Cao F

Cancer Management and Research 2018, 10:2377-2387

Published Date: 1 August 2018

Intermittent androgen deprivation therapy: recommendations to improve the management of patients with prostate cancer following the GRADE approach

Bonfill X, Arevalo-Rodriguez I, Martínez García L, Quintana MJ, Buitrago-García D, Lobos Urbina D, Cordero JA

Cancer Management and Research 2018, 10:2357-2367

Published Date: 2 August 2018

Targeting energy metabolism to eliminate cancer cells

Shahruzaman SH, Fakurazi S, Maniam S

Cancer Management and Research 2018, 10:2325-2335

Published Date: 31 July 2018

Human leukocyte antigen gene polymorphisms are associated with systemic inflammation in hepatitis B virus-related hepatocellular carcinoma

Wu XL, Li ZY, Bi XY, Zhao H, Zhao JJ, Zhou JG, Han Y, Huang Z, Zhang YF, Cai JQ

Cancer Management and Research 2018, 10:2315-2324

Published Date: 31 July 2018

Development of small-molecule therapeutics and strategies for targeting RAF kinase in BRAF-mutant colorectal cancer

Pan JH, Zhou H, Zhu SB, Huang JL, Zhao XX, Ding H, Pan YL

Cancer Management and Research 2018, 10:2289-2301

Published Date: 1 August 2018

Pooling analysis on prognostic value of PHH3 expression in cancer patients

Hao Q, Dai C, Deng Y, Xu P, Tian T, Lin S, Wang M, Liu K, Song D, Wu Y, Guo Y, Dai Z

Cancer Management and Research 2018, 10:2279-2288

Published Date: 30 July 2018

FAM98A promotes proliferation of non-small cell lung cancer cells via the P38-ATF2 signaling pathway

Zheng R, Liu Q, Wang T, Wang L, Zhang Y

Cancer Management and Research 2018, 10:2269-2278

Published Date: 27 July 2018

Disparities of age-based cancer-specific survival improvement with various clinicopathologic characteristics for kidney cancer

Liu K, Wang P, Zhu X, Bei Y, Zheng Z, Yan S

Cancer Management and Research 2018, 10:2259-2268

Published Date: 27 July 2018

MicroRNAs, long noncoding RNAs, and circular RNAs: potential tumor biomarkers and targets for colorectal cancer

Yang S, Sun Z, Zhou Q, Wang W, Wang G, Song J, Li Z, Zhang Z, Chang Y, Xia K, Liu J, Yuan W

Cancer Management and Research 2018, 10:2249-2257

Published Date: 26 July 2018

PRAF2 expression indicates unfavorable clinical outcome in hepatocellular carcinoma

Wang CH, Liu LL, Liao DZ, Zhang MF, Fu J, Lu SX, Chen SL, Wang H, Cai SH, Zhang CZ, Zhang HZ, Yun JP

Cancer Management and Research 2018, 10:2241-2248

Published Date: 25 July 2018

Prognostic value of subcutaneous adipose tissue volume in hepatocellular carcinoma treated with transcatheter intra-arterial therapy

Kobayashi T, Kawai H, Nakano O, Abe S, Kamimura H, Sakamaki A, Kamimura K, Tsuchiya A, Takamura M, Yamagiwa S, Terai S

Cancer Management and Research 2018, 10:2231-2239

Published Date: 25 July 2018

Profiles of differentially expressed circRNAs in esophageal and breast cancer

Shi P, Sun J, He B, Song H, Li Z, Kong W, Wang J, Wang JM, Xue H

Cancer Management and Research 2018, 10:2207-2221

Published Date: 23 July 2018

Preoperative circulating FPR and CCF score are promising biomarkers for predicting clinical outcome of stage II–III colorectal cancer patients

Sun F, Peng HX, Gao QF, Li SQ, Zhang J, Chen QG, Jiang YH, Zhang L, Wang XZ, Ying HQ

Cancer Management and Research 2018, 10:2151-2161

Published Date: 19 July 2018

Treatment-related adverse effects with pazopanib, sorafenib and sunitinib in patients with advanced soft tissue sarcoma: a pooled analysis

Que Y, Liang Y, Zhao JJ, Ding Y, Peng RQ, Guan YX, Zhang X

Cancer Management and Research 2018, 10:2141-2150

Published Date: 19 July 2018

Diagnostic and prognostic value of microRNAs in cholangiocarcinoma: a systematic review and meta-analysis

Sun C, Zhu J, Wu B, Chen J, Zhu Z, Cai P, Guo W, Gu Z, Wang J, Huang S

Cancer Management and Research 2018, 10:2125-2139

Published Date: 18 July 2018

Higher frequency of occult lymph node metastasis in clinical N0 pulmonary adenocarcinoma with ALK rearrangement

Seto K, Kuroda H, Yoshida T, Sakata S, Mizuno T, Sakakura N, Hida T, Yatabe Y, Sakao Y

Cancer Management and Research 2018, 10:2117-2124

Published Date: 18 July 2018

Differential diagnostic value of 18F-FDG PET/CT for benign and malignant vertebral compression fractures: comparison with magnetic resonance imaging

He X, Zhao L, Guo X, Zhao L, Wu J, Huang J, Sun L, Xie C, Chen H

Cancer Management and Research 2018, 10:2105-2115

Published Date: 18 July 2018

Right- and left-sided stage III colon cancers present different prognostic outcomes of oxaliplatin-based adjuvant chemotherapy after curative resection

Peng J, Li C, Wang F, Zhang H, Xiao W, Li H, Lu Z, Pan Z, Wu X, Zhang R

Cancer Management and Research 2018, 10:2095-2103

Published Date: 17 July 2018

Lymph node ratio as a valuable prognostic factor for patients with colorectal liver-only metastasis undergoing curative resection

Deng YX, Peng JH, Zhao YJ, Sui QQ, Zhao RX, Lu ZH, Qiu MZ, Lin JZ, Pan ZZ

Cancer Management and Research 2018, 10:2083-2094

Published Date: 17 July 2018

Nebivolol effect on doxorubicin-induced cardiotoxicity in breast cancer

Cochera F, Dinca D, Bordejevic DA, Citu IM, Mavrea AM, Andor M, Trofenciuc M, Tomescu MC

Cancer Management and Research 2018, 10:2071-2081

Published Date: 16 July 2018

Quantifying the prognostic significance of microRNA-17/17-5P in cancers: a meta-analysis based on published studies

Duan F, Yang Y, Liu W, Zhao J, Song X, Li L, Li F

Cancer Management and Research 2018, 10:2055-2069

Published Date: 17 July 2018

Long-term survival effect of the interval between mastectomy and radiotherapy in locally advanced breast cancer

Zhang WW, Wu SG, Sun JY, Li FY, He ZY

Cancer Management and Research 2018, 10:2047-2054

Published Date: 16 July 2018

Establishment of cancer/testis antigen profiling based on clinicopathological characteristics in resected pathological stage III non-small cell lung cancer

Jin S, Cao S, Grigorev A, Li J, Meng Q, Wang C, Feng M, Hu J, Jiang F, Yu Y

Cancer Management and Research 2018, 10:2031-2046

Published Date: 16 July 2018

The miR-200 family: multiple effects on gliomas

Peng L, Fu J, Ming Y

Cancer Management and Research 2018, 10:1987-1992

Published Date: 13 July 2018

Neuropilin-1 expression is associated with lymph node metastasis in breast cancer tissues

Seifi-Alan M, Shams R, Bandehpour M, Mirfakhraie R, Ghafouri-Fard S

Cancer Management and Research 2018, 10:1969-1974

Published Date: 11 July 2018

Prognostic significance of lymph node metastasis and lymphadenectomy in early-stage ovarian carcinosarcoma

Wang WP, Li N, Zhang YY, Gao YT, Sun YC, Ge L, Wu LY

Cancer Management and Research 2018, 10:1959-1968

Published Date: 10 July 2018

Direct comparison of five serum biomarkers in early diagnosis of hepatocellular carcinoma

Chen H, Zhang Y, Li S, Li N, Chen Y, Zhang B, Qu C, Ding H, Huang J, Dai M

Cancer Management and Research 2018, 10:1947-1958

Published Date: 10 July 2018

The prognostic significance of carcinoma-associated fibroblasts and tumor-associated macrophages in nasopharyngeal carcinoma

Yu Y, Ke L, Lv X, Ling Y, Lu J, Liang H, Qiu W, Huang X, Liu G, Li W, Guo X, Xia W, Xiang Y

Cancer Management and Research 2018, 10:1935-1946

Published Date: 9 July 2018

Recurrence risk after preoperative biopsy in patients with resected early-stage non-small-cell lung cancer: a retrospective study

Hu CP, Jiang J, Li YY, Zhang CF, Zhang WX, Jiang HH, Gao Y, Zhuang W, Lei KB, Tang Y, Wan RJ

Cancer Management and Research 2018, 10:1927-1934

Published Date: 6 July 2018

Prognostic significance of Ki67 expression and the derived neutrophil–lymphocyte ratio in nasopharyngeal carcinoma

Zhao L, Chen H, Hu B, Zhang H, Lin Q

Cancer Management and Research 2018, 10:1919-1926

Published Date: 5 July 2018

Safety and efficacy of denosumab in the treatment of pulmonary metastatic giant cell tumor of bone

Luo Y, Tang F, Wang Y, Zhou Y, Min L, Zhang W, Shi R, Duan H, Tu C

Cancer Management and Research 2018, 10:1901-1906

Published Date: 5 July 2018

The effect of HIF-1α and PKM1 expression on acquisition of chemoresistance

Okazaki M, Fushida S, Tsukada T, Kinoshita J, Oyama K, Miyashita T, Ninomiya I, Harada S, Ohta T

Cancer Management and Research 2018, 10:1865-1874

Published Date: 4 July 2018

Recent advances in antiemetics: new formulations of 5HT3-receptor antagonists

Gilmore J, D'Amato S, Griffith N, Schwartzberg L

Cancer Management and Research 2018, 10:1827-1857

Published Date: 3 July 2018

Polymorphisms in MYCN gene and neuroblastoma risk in Chinese children: a 3-center case–control study

Zhou H, Zhuo Z, Chen S, Zhao J, Mo Y, Zhang J, He J, Ruan J

Cancer Management and Research 2018, 10:1807-1816

Published Date: 2 July 2018

High expression of ALDOA and DDX5 are associated with poor prognosis in human colorectal cancer

Dai L, Pan G, Liu X, Huang J, Jiang Z, Zhu X, Gan X, Xu Q, Tan N

Cancer Management and Research 2018, 10:1799-1806

Published Date: 29 June 2018

CYP17 polymorphisms are associated with decreased risk of breast cancer in Chinese Han women: a case–control study

Yang P, Wang M, Tian T, Feng Y, Zheng Y, Yang T, Li H, Lin S, Xu P, Deng Y, Hao Q, Li N, Guan F, Dai Z

Cancer Management and Research 2018, 10:1791-1798

Published Date: 3 July 2018

A panel containing PD-1, IL-2Rα, IL-10, and CA15-3 as a biomarker to discriminate breast cancer from benign breast disease

Liu C, Sun B, Xu B, Meng X, Li L, Cong Y, Liu J, Wang Q, Xuan L, Song Q, Wu S

Cancer Management and Research 2018, 10:1749-1761

Published Date: 26 June 2018

Disparities in survival for right-sided vs. left-sided colon cancers in young patients: a study based on the Surveillance, Epidemiology, and End Results database (1990–2014)

Wang Y, Yang L, Zhou M, Shen L, Zhang J, Deng W, Liang L, Hu R, Yang W, Yao Y, Zhang Z

Cancer Management and Research 2018, 10:1735-1747

Published Date: 26 June 2018

The prognosis and effects of local treatment strategies for orbital embryonal rhabdomyosarcoma: a population-based study

Tang LY, Zhang MX, Lu DH, Chen YX, Liu ZG, Wu SG

Cancer Management and Research 2018, 10:1727-1734

Published Date: 25 June 2018

The prognostic value of differentially expressed CYP3A subfamily members for hepatocellular carcinoma

Yu T, Wang X, Zhu G, Han C, Su H, Liao X, Yang C, Qin W, Huang K, Peng T

Cancer Management and Research 2018, 10:1713-1726

Published Date: 25 June 2018

Cervical lymph node metastases in salivary gland adenoid cystic carcinoma: a systematic review and meta-analysis

Ning C, Zhao T, Wang Z, Li D, Kou Y, Huang S

Cancer Management and Research 2018, 10:1677-1685

Published Date: 22 June 2018

Cancer risk assessment in modern radiotherapy workflow with medical big data

Jin F, Luo HL, Zhou J, He YN, Liu XF, Zhong MS, Yang H, Li C, Li QC, Huang X, Tian XM, Qiu D, He GL, Yin L, Wang Y

Cancer Management and Research 2018, 10:1665-1675

Published Date: 22 June 2018

miRNA-146a rs2910164 C>G polymorphism increased the risk of esophagogastric junction adenocarcinoma: a case–control study involving 2,740 participants

Chen Y, Tang W, Liu C, Lin J, Wang Y, Zhang S, Chen G, Zheng X

Cancer Management and Research 2018, 10:1657-1664

Published Date: 25 June 2018

Decreased expression of TRPV1 in renal cell carcinoma: association with tumor Fuhrman grades and histopathological subtypes

Wu YY, Liu XY, Zhuo DX, Huang HB, Zhang FB, Liao SF

Cancer Management and Research 2018, 10:1647-1655

Published Date: 22 June 2018

The homogeneous and heterogeneous risk factors for the morbidity and prognosis of bone metastasis in patients with prostate cancer

Guo X, Zhang C, Guo Q, Xu Y, Feng G, Li L, Han X, Lu F, Ma Y, Wang X, Wang G

Cancer Management and Research 2018, 10:1639-1646

Published Date: 22 June 2018

Pioglitazone use in patients with diabetes and risk of bladder cancer: a systematic review and meta-analysis

Yan H, Xie H, Ying Y, Li J, Wang X, Xu X, Zheng X

Cancer Management and Research 2018, 10:1627-1638

Published Date: 22 June 2018

Role of key players in paradigm shifts of prostate cancer bone metastasis

Sohail A, Sherin L, Butt SI, Javed S, Li Z, Iqbal S, Be'g OA

Cancer Management and Research 2018, 10:1619-1626

Published Date: 21 June 2018

Optimal management of resected gastric cancer

Giampieri R, Del Prete M, Cantini L, Baleani MG, Bittoni A, Maccaroni E, Berardi R

Cancer Management and Research 2018, 10:1605-1618

Published Date: 21 June 2018

An increased number of negative lymph nodes is associated with a higher immune response and longer survival in colon cancer patients

He WZ, Xie QK, Hu WM, Kong PF, Yang L, Yang YZ, Jiang C, Yin CX, Qiu HJ, Zhang HZ, Zhang B, Xia LP

Cancer Management and Research 2018, 10:1597-1604

Published Date: 18 June 2018

INHBA upregulation correlates with poorer prognosis in patients with esophageal squamous cell carcinoma

Lyu S, Jiang C, Xu R, Huang Y, Yan S

Cancer Management and Research 2018, 10:1585-1596

Published Date: 18 June 2018

Synaptopodin-2 plays an important role in the metastasis of breast cancer via PI3K/Akt/mTOR pathway

Xia E, Zhou X, Bhandari A, Zhang X, Wang O

Cancer Management and Research 2018, 10:1575-1583

Published Date: 18 June 2018

Knowledge, attitude, and practice toward the daily management of PICC in critically ill cancer patients discharged from intensive care units

Chen J, Zhao H, Xia Z, Zhang Y, Lv X, Zhou X, Dong X, Li J, Jiang H, Huang Y, Huang H

Cancer Management and Research 2018, 10:1565-1574

Published Date: 18 June 2018

Expression of 4E-BP1 and phospho-4E-BP1 correlates with the prognosis of patients with clear cell renal carcinoma

Li F, Wang Q, Xiong X, Wang CY, Liu X, Liao ZQ, Li K, Xie B, Lin Y

Cancer Management and Research 2018, 10:1553-1563

Published Date: 15 June 2018

Comparison of NSAIDs activity in COX-2 expressing and non-expressing 2D and 3D pancreatic cancer cell cultures

Čeponytė U, Paškevičiūtė M, Petrikaitė V

Cancer Management and Research 2018, 10:1543-1551

Published Date: 15 June 2018

A nomogram to predict overall survival for biliary tract cancer

Song W, Zhu Z, Wu Q, Lv C, Wang Y, Chen L, Miao D

Cancer Management and Research 2018, 10:1535-1541

Published Date: 14 June 2018

Multifocality is associated with central neck lymph node metastases in papillary thyroid microcarcinoma

Zheng W, Wang K, Wu J, Wang W, Shang J

Cancer Management and Research 2018, 10:1527-1533

Published Date: 14 June 2018

A two-microRNA signature as a diagnostic and prognostic marker of pancreatic adenocarcinoma

Yu Y, Feng X, Cang S

Cancer Management and Research 2018, 10:1507-1515

Published Date: 13 June 2018

Genetic polymorphisms in the TERT gene and susceptibility to non-small cell lung cancer in a Chinese Han population

Li C, Wang X, Li Y, Zhang X, Sun M, Liu S, Sun L, Shi L, Yao Y

Cancer Management and Research 2018, 10:1487-1495

Published Date: 11 June 2018

Expression and clinical significance of autophagic protein LC3B and EMT markers in gastric cancer

Wang JY, Wu T, Ma W, Li S, Jing WJ, Ma J, Chen DM, Guo XJ, Nan KJ

Cancer Management and Research 2018, 10:1479-1486

Published Date: 11 June 2018

Poor prognosis and SATB1 overexpression in solid tumors: a meta-analysis

Wang S, Zeng J, Xiao R, Xu G, Liu G, Xiong D, Ye Y, Chen B, Wang H, Luo Q, Huang Z

Cancer Management and Research 2018, 10:1471-1478

Published Date: 8 June 2018

Extramedullary hematopoiesis secondary to malignant solid tumors: a case report and literature review

Bao Y, Liu Z, Guo M, Li B, Sun X, Wang L

Cancer Management and Research 2018, 10:1461-1470

Published Date: 8 June 2018

LncRNAs and EGFRvIII sequestered in TEPs enable blood-based NSCLC diagnosis

Luo CL, Xu ZG, Chen H, Ji J, Wang YH, Hu W, Wang K, Zhang WW, Yuan CH, Wang FB

Cancer Management and Research 2018, 10:1449-1459

Published Date: 8 June 2018

Notch signaling pathway mediates Doxorubicin-driven apoptosis in cancers

Huang Z, Lin S, Long C, Zhou X, Fan Y, Kuang X, He J, Ning J, Zhang H, Zhang Q, Shen H

Cancer Management and Research 2018, 10:1439-1448

Published Date: 8 June 2018

Influence of TS (rs34743033) and RUNX1 (rs2014300) gene polymorphisms on survival outcomes of fluorouracil-based chemotherapy in Chinese advanced gastric cancer patients

Han R, Wei J, Zhang H, Su X, Chu X, Chen Y, Gong Y, Wang X, Shi J, Chen J

Cancer Management and Research 2018, 10:1429-1437

Published Date: 6 June 2018

Prognostic value and clinical significance of long noncoding RNA CASC2 in human malignancies: a meta-analysis

Cai J, Zuo X, Chen Z, Zhao W, Zhu Y, Zhang Z, Ye X

Cancer Management and Research 2018, 10:1403-1412

Published Date: 31 May 2018

Performance status dynamics during treatment with nab-paclitaxel plus gemcitabine versus gemcitabine alone for metastatic pancreatic cancer

Chiorean EG, Von Hoff D, Wan Y, Margunato-Debay S, Botteman M, Goldstein D

Cancer Management and Research 2018, 10:1389-1396

Published Date: 31 May 2018

Polymorphism in lncRNA AC008392.1 and its interaction with smoking on the risk of lung cancer in a Chinese population

Lv X, Cui Z, Li H, Li J, Yang Z, Bi Y, Gao M, Zhou B, Yin Z

Cancer Management and Research 2018, 10:1377-1387

Published Date: 30 May 2018

Tumor-infiltrating lymphocyte as a prognostic biomarker in stage IV colorectal cancer should take into account the metastatic status and operation modality

Xie QK, He WZ, Hu WM, Yang L, Jiang C, Kong PF, Yang YZ, Yang Q, Zhang HZ, Zhang B, Xia LP

Cancer Management and Research 2018, 10:1365-1375

Published Date: 30 May 2018

Age distribution and age-related outcomes of olfactory neuroblastoma: a population-based analysis

Yin ZZ, Wang YY, Wu YM, Zhang XM, Wang FM, Wang PG, Tao Z, Yuan ZY

Cancer Management and Research 2018, 10:1359-1364

Published Date: 29 May 2018

Clinical effect of MUC1 and its relevance to BRAF V600E mutation in papillary thyroid carcinoma: a case–control study

Li Q, Jin W, Jin Y, Zheng Z, Zhou X, Wang Q, Ye D, Sun Y, Zhang X, Wang O, Chen E, Cai Y

Cancer Management and Research 2018, 10:1351-1358

Published Date: 29 May 2018

Elevated expression of podoplanin and its clinicopathological, prognostic, and therapeutic values in squamous non-small cell lung cancer

Xie L, Lin C, Zhang Q, Piao H, Bigner DD, Zhang Z, Bao X

Cancer Management and Research 2018, 10:1329-1340

Published Date: 24 May 2018

Matching-adjusted indirect treatment comparison of ribociclib and palbociclib in HR+, HER2− advanced breast cancer

Tremblay G, Chandiwana D, Dolph M, Hearnden J, Forsythe A, Monaco M

Cancer Management and Research 2018, 10:1319-1327

Published Date: 22 May 2018

Association of FGFR2 and PI3KCA genetic variants with the risk of breast cancer in a Chinese population

Wang Y, Zhang H, Lin M, Wang Y

Cancer Management and Research 2018, 10:1305-1311

Published Date: 21 May 2018

Associated factors for oral health problems in a sample of Saudi cancer patients

Yenugadhati N, Albalawi AN, Qureshey AT, Qureshey ET, Al-Jahdali H, Jazieh AR, Ahmed AE

Cancer Management and Research 2018, 10:1285-1293

Published Date: 21 May 2018

Severe cutaneous adverse reactions induced by targeted anticancer therapies and immunotherapies

Chen CB, Wu MY, Ng CY, Lu CW, Wu J, Kao PH, Yang CK, Peng MT, Huang CY, Chang WC, Hui RCY, Yang CH, Yang SF, Chung WH, Su SC

Cancer Management and Research 2018, 10:1259-1273

Published Date: 17 May 2018

Expression and significance of RRBP1 in esophageal carcinoma

Wang L, Wang M, Zhang M, Li X, Zhu Z, Wang H

Cancer Management and Research 2018, 10:1243-1249

Published Date: 17 May 2018

Dichloroacetate enhances the antitumor efficacy of chemotherapeutic agents via inhibiting autophagy in non-small-cell lung cancer

Lu X, Zhou D, Hou B, Liu QX, Chen Q, Deng XF, Yu ZB, Dai JG, Zheng H

Cancer Management and Research 2018, 10:1231-1241

Published Date: 16 May 2018

Role of Lactobacillus in cervical cancer

Yang X, Da M, Zhang W, Qi Q, Zhang C, Han S

Cancer Management and Research 2018, 10:1219-1229

Published Date: 16 May 2018

Diagnostic accuracy of droplet digital PCR for detection of EGFR T790M mutation in circulating tumor DNA

Zhang R, Chen B, Tong X, Wang Y, Wang C, Jin J, Tian P, Li W

Cancer Management and Research 2018, 10:1209-1218

Published Date: 16 May 2018

Incidental thyroid carcinoma in surgery-treated hyperthyroid patients with Graves’ disease: a systematic review and meta-analysis of cohort studies

Jia Q, Li X, Liu Y, Li L, Kwong JSW, Ren K, Jiang Y, Sun X, Tian H, Li S

Cancer Management and Research 2018, 10:1201-1207

Published Date: 21 May 2018

Prognostic factors for survival among patients with primary bone sarcomas of small bones

Wang Z, Li S, Li Y, Lin N, Huang X, Liu M, Pan WB, Yan XB, Sun LL, Li HY, Li BH, Qu H, Wu Y, Lin P, Ye ZM

Cancer Management and Research 2018, 10:1191-1199

Published Date: 14 May 2018

Preoperative serum apolipoprotein A-I levels predict long-term survival in non-muscle-invasive bladder cancer patients

Shang Z, Wang J, Wang X, Yan H, Cui B, Jia C, Wang Q, Cui X, Li J, Ou T

Cancer Management and Research 2018, 10:1177-1190

Published Date: 14 May 2018

Overexpression of chloride channel-3 predicts unfavorable prognosis and promotes cellular invasion in gastric cancer

Peng J, Chen W, Chen J, Yuan Y, Zhang J, He Y

Cancer Management and Research 2018, 10:1163-1175

Published Date: 14 May 2018

The lncRNA myocardial infarction associated transcript-centric competing endogenous RNA network in non-small-cell lung cancer

Zheng C, Li X, Qian B, Feng N, Gao S, Zhao Y, Zhou B

Cancer Management and Research 2018, 10:1155-1162

Published Date: 14 May 2018

MC1R variants as melanoma risk factors independent of at-risk phenotypic characteristics: a pooled analysis from the M-SKIP project

Tagliabue E, Gandini S, Bellocco R, Maisonneuve P, Newton-Bishop J, Polsky D, Lazovich D, Kanetsky PA, Ghiorzo P, Gruis NA, Landi MT, Menin C, Fargnoli MC, García-Borrón JC, Han J, Little J, Sera F, Raimondi S

Cancer Management and Research 2018, 10:1143-1154

Published Date: 14 May 2018

Decreased survival in patients with carcinoma of axillary tail versus upper outer quadrant breast cancers: a SEER population-based study

Gou ZC, Liu XY, Xiao Y, Zhao S, Jiang YZ, Shao ZM

Cancer Management and Research 2018, 10:1133-1141

Published Date: 14 May 2018

A review of soft-tissue sarcomas: translation of biological advances into treatment measures

Hoang NT, Acevedo LA, Mann MJ, Tolani B

Cancer Management and Research 2018, 10:1089-1114

Published Date: 10 May 2018

Andrographolide potentiates the antitumor effect of topotecan in acute myeloid leukemia cells through an intrinsic apoptotic pathway

Hodroj MH, Jardaly A, Abi Raad S, Zouein A, Rizk S

Cancer Management and Research 2018, 10:1079-1088

Published Date: 10 May 2018

Genetic variants of ALDH2-rs671 and CYP2E1-rs2031920 contributed to risk of hepatocellular carcinoma susceptibility in a Chinese population

Ye X, Wang X, Shang L, Zhu G, Su H, Han C, Qin W, Li G, Peng T

Cancer Management and Research 2018, 10:1037-1050

Published Date: 4 May 2018

Genetic variants in the exon region of versican predict survival of patients with resected early-stage hepatitis B virus-associated hepatocellular carcinoma

Liu X, Han C, Liao X, Yu L, Zhu G, Su H, Qin W, Lu S, Ye X, Peng T

Cancer Management and Research 2018, 10:1027-1036

Published Date: 4 May 2018

Is progression-free survival a more relevant endpoint than overall survival in first-line HR+/HER2− metastatic breast cancer?

Forsythe A, Chandiwana D, Barth J, Thabane M, Baeck J, Shor A, Tremblay G

Cancer Management and Research 2018, 10:1015-1025

Published Date: 4 May 2018

Co-existence of BRAFV600E and TERT promoter mutations in papillary thyroid carcinoma is associated with tumor aggressiveness, but not with lymph node metastasis

Ren HY, Shen YF, Hu DX, He W, Zhou J, Cao YJ, Mao Y, Dou Y, Xiong W, Xiao Q, Zhang YH, Su XL

Cancer Management and Research 2018, 10:1005-1013

Published Date: 3 May 2018

MiR-497-5p, miR-195-5p and miR-455-3p function as tumor suppressors by targeting hTERT in melanoma A375 cells

Chai L, Kang XJ, Sun ZZ, Zeng MF, Yu SR, Ding Y, Liang JQ, Li TT, Zhao J

Cancer Management and Research 2018, 10:989-1003

Published Date: 3 May 2018

ITGA7 functions as a tumor suppressor and regulates migration and invasion in breast cancer

Bhandari A, Xia E, Zhou Y, Guan Y, Xiang J, Kong L, Wang Y, Yang F, Wang O, Zhang X

Cancer Management and Research 2018, 10:969-976

Published Date: 1 May 2018

Durvalumab: a potential maintenance therapy in surgery-ineligible non-small-cell lung cancer

Shafique MR, Robinson LA, Antonia S

Cancer Management and Research 2018, 10:931-940

Published Date: 1 May 2018

Prognostic value of microRNAs in colorectal cancer: a meta-analysis

Gao S, Zhao ZY, Wu R, Zhang Y, Zhang ZY

Cancer Management and Research 2018, 10:907-929

Published Date: 30 April 2018

A favorable tumor size to define papillary thyroid microcarcinoma: an analysis of 1176 consecutive cases

Gong YP, Li GP, Lei JY, You JY, Jiang K, Li ZH, Gong RX, Zhu JQ

Cancer Management and Research 2018, 10:899-906

Published Date: 27 April 2018

Liver-enriched activator protein 1 as an isoform of CCAAT/enhancer-binding protein beta suppresses stem cell features of hepatocellular carcinoma

Yang LH, Wang Y, Qiao S, Wang MJ, Chen F, Zi XY, Li JX, Zhang HB, Yu B, Hu YP

Cancer Management and Research 2018, 10:873-885

Published Date: 26 April 2018

Association of two FOXP3 polymorphisms with breast cancer susceptibility in Chinese Han women

Tian T, Wang M, Zheng Y, Yang T, Zhu W, Li H, Lin S, Liu K, Xu P, Deng Y, Zhou L, Dai Z

Cancer Management and Research 2018, 10:867-872

Published Date: 26 April 2018

Elevated circulating miR-182 acts as a diagnostic biomarker for early colorectal cancer

Liu X, Xu T, Hu X, Chen X, Zeng K, Sun L, Wang S

Cancer Management and Research 2018, 10:857-865

Published Date: 24 April 2018

A novel nomogram for the prediction of intrahepatic cholangiocarcinoma in patients with intrahepatic lithiasis complicated by imagiologically diagnosed mass

Chen G, Yu H, Wang Y, Li C, Zhou M, Yu Z, Zheng X, Wu X, Shan Y, Zhang Q, Zeng Q

Cancer Management and Research 2018, 10:847-856

Published Date: 23 April 2018

Transoral robotic surgery for oropharyngeal cancer: patient selection and special considerations

Baskin RM, Boyce BJ, Amdur R, Mendenhall WM, Hitchcock K, Silver N, Dziegielewski PT

Cancer Management and Research 2018, 10:839-846

Published Date: 20 April 2018

Emergency treatment of complicated colorectal cancer

Tebala GD, Natili A, Gallucci A, Brachini G, Khan AQ, Tebala D, Mingoli A

Cancer Management and Research 2018, 10:827-838

Published Date: 20 April 2018

Effective prevention of sorafenib-induced hand–foot syndrome by dried-bonito broth

Kamimura K, Shinagawa-Kobayashi Y, Goto R, Ogawa K, Yokoo T, Sakamaki A, Abe S, Kamimura H, Suda T, Baba H, Tanaka T, Nozawa Y, Koyama N, Takamura M, Kawai H, Yamagiwa S, Aoyagi Y, Terai S

Cancer Management and Research 2018, 10:805-813

Published Date: 17 April 2018

Identification of potential prognostic microRNA biomarkers for predicting survival in patients with hepatocellular carcinoma

Liao X, Zhu G, Huang R, Yang C, Wang X, Huang K, Yu T, Han C, Su H, Peng T

Cancer Management and Research 2018, 10:787-803

Published Date: 13 April 2018

MicroRNA-142-3p is involved in regulation of MGMT expression in glioblastoma cells

Lee YY, Yarmishyn AA, Wang ML, Chen HY, Chiou S, Yang YP, Lin C, Huang PI, Chen YW, Ma HI, Chen M

Cancer Management and Research 2018, 10:775-785

Published Date: 12 April 2018

Genetic variants in the nucleotide excision repair pathway genes and gastric cancer susceptibility in a southern Chinese population

He J, Zhuo Z, Zhang A, Zhu J, Hua R, Xue W, Zhang S, Zhang J, Li X, Jia W

Cancer Management and Research 2018, 10:765-774

Published Date: 12 April 2018

Quantitative assessment of the clinical susceptibility of calcium-sensing receptor polymorphisms in cancer patients

Huang H, Li T, Liao D, Zhu Z, Dong Y

Cancer Management and Research 2018, 10:755-763

Published Date: 12 April 2018

The role of the pathology department in the preanalytical phase of molecular analyses

Susman S, Berindan-Neagoe I, Petrushev B, Pirlog R, Florian IS, Mihu CM, Berce C, Craciun L, Grewal R, Tomuleasa C

Cancer Management and Research 2018, 10:745-753

Published Date: 12 April 2018

Management of hemorrhage in gastrointestinal stromal tumors: a review

Liu Q, Kong F, Zhou J, Dong M, Dong Q

Cancer Management and Research 2018, 10:735-743

Published Date: 12 April 2018

Deciphering hepatocellular carcinoma through metabolomics: from biomarker discovery to therapy evaluation

Guo W, Tan HY, Wang N, Wang XB, Feng YB

Cancer Management and Research 2018, 10:715-734

Published Date: 11 April 2018

The association of polymorphisms in miRNAs with nonsmall cell lung cancer in a Han Chinese population

Li C, Zhang Y, Li Y, Ma Q, Liu S, Yao Y, Tan F, Shi L, Yao Y

Cancer Management and Research 2018, 10:697-704

Published Date: 10 April 2018

The impact of the lymph node density on overall survival in patients with Wilms’ tumor: A SEER analysis

You H, Yang J, Liu Q, Tang L, Bu Q, Pan Z, Lyu J

Cancer Management and Research 2018, 10:671-677

Published Date: 6 April 2018

ANLN functions as a key candidate gene in cervical cancer as determined by integrated bioinformatic analysis

Xia L, Su X, Shen J, Meng Q, Yan J, Zhang C, Chen Y, Wang H, Xu M

Cancer Management and Research 2018, 10:663-670

Published Date: 5 April 2018

Poorer prognosis in young female patients with non-metastatic colorectal cancer: a hospital-based analysis of 5,047 patients in China

Shen L, Mo M, Jia L, Jia H, Li Q, Liang L, Shi D, Zhang Z, Cai S, Li X, Zhu J

Cancer Management and Research 2018, 10:653-661

Published Date: 4 April 2018

The association between long-term conditions and uptake of population-based screening for colorectal cancer: results from two English cohort studies

Kearns B, Chilcott J, Relton C, Whyte S, Woods HB, Nickerson C, Loban A

Cancer Management and Research 2018, 10:637-645

Published Date: 28 March 2018

Prognostic significance of leukopenia during the induction phase in adult B cell acute lymphoblastic leukemia

Xing C, Liang B, Wu J, Yang Q, Hu G, Yan Y, Zhang Y, Jiang S, Yu K, Feng J

Cancer Management and Research 2018, 10:625-635

Published Date: 28 March 2018

Management of relapsed/refractory marginal zone lymphoma: focus on ibrutinib

Denlinger NM, Epperla N, William BM

Cancer Management and Research 2018, 10:615-624

Published Date: 27 March 2018

Economic burden of the management of metastatic castrate-resistant prostate cancer in Italy: a cost of illness study [Corrigendum]

Restelli U, Ceresoli GL, Croce D, Evangelista L, Maffioli LS, Gianoncelli L, Bombardieri E

Cancer Management and Research 2018, 10:613-614

Published Date: 27 March 2018

The mutation of hepatitis B virus and the prognosis of hepatocellular carcinoma after surgery: a pilot study

Zhang Y, Huang J, Chen J, Yang K, Chen J, Xu L, Zhou Z, Chen M

Cancer Management and Research 2018, 10:599-611

Published Date: 27 March 2018

SYK expression level distinguishes control from BRCA1-mutated lymphocytes

Zahavi T, Sonnenblick A, Shimshon Y, Kadouri L, Peretz T, Salmon AY, Salmon-Divon M

Cancer Management and Research 2018, 10:589-598

Published Date: 26 March 2018

Bimodality treatment of patients with pelvic adenoid cystic carcinoma with photon intensity-modulated radiotherapy plus carbon ion boost: a case series

Bernhardt D, Sterzing F, Adeberg S, Herfarth K, Katayama S, Foerster R, Hoerner-Rieber J, König L, Debus J, Rieken S

Cancer Management and Research 2018, 10:583-588

Published Date: 26 March 2018

L61H46 shows potent efficacy against human pancreatic cancer through inhibiting STAT3 pathway

Bai E, Yang L, Xiang Y, Hu W, Li C, Lin J, Dai X, Liang G, Jin R, Zhao C

Cancer Management and Research 2018, 10:565-581

Published Date: 23 March 2018

Management and prognosis of patients with liver metastases from gestational trophoblastic neoplasia: a retrospective cohort study

Zong LJ, Yang JJ, Wang XY, Kong YJ, Ren T, Zhao J, Feng FZ, Wan XR, Xiang Y

Cancer Management and Research 2018, 10:557-563

Published Date: 23 March 2018

Mechanical ventilation promotes lung metastasis in experimental 4T1 breast cancer lung-metastasized models

Huang YL, Pan L, Helou K, Xia QS, Parris TZ, Li HY, Xu B, Li H

Cancer Management and Research 2018, 10:545-555

Published Date: 20 March 2018

Downregulation of hsa_circ_0011946 suppresses the migration and invasion of the breast cancer cell line MCF-7 by targeting RFC3

Zhou J, Zhang WW, Peng F, Sun JY, He ZY, Wu SG

Cancer Management and Research 2018, 10:535-544

Published Date: 19 March 2018

Prospective study of neoadjuvant chemoradiotherapy using intensity-modulated radiotherapy and 5 fluorouracil for locally advanced rectal cancer – toxicities and response assessment

Simson DK, Mitra S, Ahlawat P, Saxena U, Kumar Sharma M, Rawat S, Singh H, Bansal B, Sripathi LK, Tanwar A

Cancer Management and Research 2018, 10:519-526

Published Date: 19 March 2018

Primary clear cell carcinoma of the thymus and literature comparison of features

Dai X, Zhao L, Peng F

Cancer Management and Research 2018, 10:513-518

Published Date: 16 March 2018

Upregulation of Arp2 expression is associated with the prognosis and prediction of lymph node metastasis in bladder urothelial carcinoma

Xu N, Qu GY, Wu YP, Li XD, Lin MY, Chen SH, Xue XY, Wei Y

Cancer Management and Research 2018, 10:503-511

Published Date: 19 March 2018

Immunocompetence and mechanism of the DRibble-DCs vaccine for oral squamous cell carcinoma

Dong H, Su H, Chen L, Liu K, Hu HM, Yang WD, Mou YB

Cancer Management and Research 2018, 10:493-501

Published Date: 16 March 2018

Intensity of treatment in Swiss cancer patients at the end-of-life

Bähler C, Signorell A, Blozik E, Reich O

Cancer Management and Research 2018, 10:481-491

Published Date: 15 March 2018

Moderate hypofractionated radiotherapy after prostatectomy for cancer patients: toxicity and clinical outcome

Barra S, Belgioia L, Marcenaro M, Callegari S, Pastorino A, Trapani L, Cavagnetto F, Garelli S, Corvò R

Cancer Management and Research 2018, 10:473-480

Published Date: 12 March 2018

Clinical behaviors of rare variants of papillary thyroid carcinoma are associated with survival: a population-level analysis

Jiang CH, Cheng T, Zheng XC, Hong SK, Liu S, Liu JJ, Wang J, Wang SY

Cancer Management and Research 2018, 10:465-472

Published Date: 9 March 2018

Adenosquamous carcinoma of the bile duct: a population-based study

Qin BD, Jiao XD, Yuan LY, Liu K, Zang YS

Cancer Management and Research 2018, 10:439-446

Published Date: 7 March 2018

A novel mechanism of tumor-induced thymic atrophy in mice bearing H22 hepatocellular carcinoma

Sun SJ, Ji HY, Feng YY, Kang Y, Yu J, Liu AJ

Cancer Management and Research 2018, 10:417-424

Published Date: 5 March 2018

Bax, Bcl-2, and Bax/Bcl-2 as prognostic markers in acute myeloid leukemia: are we ready for Bcl-2-directed therapy?

Kulsoom B, Shamsi TS, Afsar NA, Memon Z, Ahmed N, Hasnain SN

Cancer Management and Research 2018, 10:403-416

Published Date: 2 March 2018

Coordination of FOXA2 and SIRT6 suppresses the hepatocellular carcinoma progression through ZEB2 inhibition

Liu J, Yu Z, Xiao Y, Meng Q, Wang Y, Chang W

Cancer Management and Research 2018, 10:391-402

Published Date: 1 March 2018

Quality of life of young Chinese breast cancer patients after adjuvant chemotherapy

Yeo W, Mo FKF, Pang E, Suen JJS, Koh J, Yip CHW, Yip CCH, Li L, Loong HHF, Liem GS

Cancer Management and Research 2018, 10:383-389

Published Date: 22 February 2018

Surgical resection improves long-term survival of patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages

Guo H, Wu T, Lu Q, Li M, Guo JY, Shen Y, Wu Z, Nan KJ, Lv Y, Zhang XF

Cancer Management and Research 2018, 10:361-369

Published Date: 21 February 2018

Patients with osteosarcoma and soft tissue sarcoma might become "cancer refugees" in some Japanese regional cities

Yamane H, Kunisada T, Ozaki T, Ochi N, Honda Y, Nagasaki Y, Nakagawa N, Yamagishi T, Nakanishi H, Takigawa N

Cancer Management and Research 2018, 10:353-359

Published Date: 19 February 2018

MicroRNA–mRNA expression profiles associated with medulloblastoma subgroup 4

Gershanov S, Toledano H, Michowiz S, Barinfeld O, Pinhasov A, Goldenberg-Cohen N, Salmon-Divon M

Cancer Management and Research 2018, 10:339-352

Published Date: 16 February 2018

The role of calgranulin B gene on the biological behavior of squamous cervical cancer in vitro and in vivo

Zhang W, Chen M, Cheng H, Shen Q, Wang Y, Zhu X

Cancer Management and Research 2018, 10:323-338

Published Date: 16 February 2018

Combination of CRP and NLR: a better predictor of postoperative survival in patients with gastric cancer

Guo J, Chen S, Chen Y, Li S, Xu D

Cancer Management and Research 2018, 10:315-321

Published Date: 14 February 2018

Husbands’ perceptions of their wives’ breast cancer coping efficacy: testing congruence models of adjustment

Merluzzi TV, Martinez Sanchez M

Cancer Management and Research 2018, 10:297-304

Published Date: 12 February 2018

Bone metastasis pattern in initial metastatic breast cancer: a population-based study

Xiong Z, Deng G, Huang X, Li X, Xie X, Wang J, Shuang Z, Wang X

Cancer Management and Research 2018, 10:287-295

Published Date: 9 February 2018

Neoadjuvant chemotherapy among patients treated for nonmetastatic breast cancer in a population with a high HIV prevalence in Johannesburg, South Africa

Ruff P, Cubasch H, Joffe M, Rosenbaum E, Murugan N, Tsai MC, Ayeni O, Crew KD, Jacobson JS, Neugut AI

Cancer Management and Research 2018, 10:279-286

Published Date: 9 February 2018

Uncemented three-dimensional-printed prosthetic replacement for giant cell tumor of distal radius: a new design of prosthesis and surgical techniques

Lu MX, Min L, Xiao C, Li YJ, Luo Y, Zhou Y, Zhang WL, Tu CQ

Cancer Management and Research 2018, 10:265-277

Published Date: 8 February 2018

Anastomotic reinforcement with omentoplasty reduces anastomotic leakage for minimally invasive esophagectomy with cervical anastomosis

Zhou D, Liu QX, Deng XF, Zheng H, Lu X, Dai JG, Jiang L

Cancer Management and Research 2018, 10:257-263

Published Date: 7 February 2018

Comparative effectiveness of early-line nab-paclitaxel vs. paclitaxel in patients with metastatic breast cancer: a US community-based real-world analysis

Mahtani RL, Parisi M, Glück S, Ni Q, Park S, Pelletier C, Faria C, Braiteh F

Cancer Management and Research 2018, 10:249-256

Published Date: 8 February 2018

Gastric cancer: epidemiology, prevention, classification, and treatment

Sitarz R, Skierucha M, Mielko J, Offerhaus GJA, Maciejewski R, Polkowski WP

Cancer Management and Research 2018, 10:239-248

Published Date: 7 February 2018

Comparison of prognostic prediction between nomogram based on lymph node ratio and AJCC 8th staging system for patients with resected pancreatic head carcinoma: a SEER analysis

Pu N, Li JA, Xu YL, Lee WL, Fang Y, Han X, Zhao GC, Zhang L, Nuerxiati A, Yin HL, Wu WC, Lou WH

Cancer Management and Research 2018, 10:227-238

Published Date: 5 February 2018

Advances in the treatment of soft tissue sarcoma: focus on eribulin

Koliou P, Karavasilis V, Theochari M, Pollack SM, Jones RL, Thway K

Cancer Management and Research 2018, 10:207-216

Published Date: 1 February 2018

Role of intestinal flora in colorectal cancer from the metabolite perspective: a systematic review

Han S, Gao J, Zhou Q, Liu S, Wen C, Yang X

Cancer Management and Research 2018, 10:199-206

Published Date: 31 January 2018

Early diagnostic potential of APC hypermethylation in esophageal cancer

Wang B, Song H, Jiang H, Fu Y, Ding X, Zhou C

Cancer Management and Research 2018, 10:181-198

Published Date: 1 February 2018

Adrenal myelolipoma with hyperandrogenemia and schizophrenia

Liu N, Zhang W, Tan J, Zhou J, Yu X, Ren N, Fang Z, Jiao W, Fan Y, Liu C

Cancer Management and Research 2018, 10:177-180

Published Date: 1 February 2018

Treatment and outcomes of non-small-cell lung cancer patients with high comorbidity

Rios J, Gosain R, Goulart BHL, Huang B, Oechsli MN, McDowell JK, Chen Q, Tucker T, Kloecker GH

Cancer Management and Research 2018, 10:167-175

Published Date: 24 January 2018

Solute carrier transporters: potential targets for digestive system neoplasms

Xie J, Zhu XY, Liu LM, Meng ZQ

Cancer Management and Research 2018, 10:153-166

Published Date: 24 January 2018

Association between body mass index and breast cancer risk: evidence based on a dose–response meta-analysis

Liu K, Zhang W, Dai Z, Wang M, Tian T, Liu X, Kang H, Guan H, Zhang S, Dai Z

Cancer Management and Research 2018, 10:143-151

Published Date: 18 January 2018

Radiation-induced secondary malignancies for nasopharyngeal carcinoma: a pilot study of patients treated via IMRT or VMAT

Lee HF, Lan JH, Chao PJ, Ting HM, Chen HC, Hsu HC, Lee TF

Cancer Management and Research 2018, 10:131-141

Published Date: 18 January 2018

The role of brigatinib in crizotinib-resistant non-small cell lung cancer

Mezquita L, Planchard D

Cancer Management and Research 2018, 10:123-130

Published Date: 18 January 2018

A comparison of QuantStudio™ 3D Digital PCR and ARMS-PCR for measuring plasma EGFR T790M mutations of NSCLC patients

Feng Q, Gai F, Sang Y, Zhang J, Wang P, Wang Y, Liu B, Lin D, Yu Y, Fang J

Cancer Management and Research 2018, 10:115-121

Published Date: 18 January 2018

The relationship between the PD-1/PD-L1 pathway and DNA mismatch repair in cervical cancer and its clinical significance

Feng YC, Ji WL, Yue N, Huang YC, Ma XM

Cancer Management and Research 2018, 10:105-113

Published Date: 18 January 2018

Neoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going

Omarini C, Guaitoli G, Pipitone S, Moscetti L, Cortesi L, Cascinu S, Piacentini F

Cancer Management and Research 2018, 10:91-103

Published Date: 15 January 2018

Toxic elements as biomarkers for breast cancer: a meta-analysis study

Jouybari L, Saei Ghare Naz M, Sanagoo A, Kiani F, Sayehmiri F, Sayehmiri K, Hasanpour Dehkordi A

Cancer Management and Research 2018, 10:69-79

Published Date: 10 January 2018

Vulvar carcinoma: dilemma, debates, and decisions

Mitra S, Kumar Sharma M, Kaur I, Khurana R, Batra Modi K, Narang R, Mandal A, Dutta S

Cancer Management and Research 2018, 10:61-68

Published Date: 9 January 2018

Detection of circulating tumor cells in liquid biopsy from Ewing sarcoma patients

Benini S, Gamberi G, Cocchi S, Garbetta J, Alberti L, Righi A, Gambarotti M, Picci P, Ferrari S

Cancer Management and Research 2018, 10:49-60

Published Date: 9 January 2018

Young age increases risk for lymph node positivity but decreases risk for non-small cell lung cancer death

Xia W, Wang A, Jin M, Mao Q, Xia W, Dong G, Chen B, Ma W, Xu L, Jiang F

Cancer Management and Research 2018, 10:41-48

Published Date: 8 January 2018

The reciprocal relationship between coping mechanisms and lung cancer diagnosis: findings of a prospective study

Oancea C, Suciu C, Timar B, Papava I, Raica M, Burlacu O

Cancer Management and Research 2018, 10:33-40

Published Date: 4 January 2018

Effects of marital status on survival of hepatocellular carcinoma by race/ethnicity and gender

Wu W, Fang D, Shi D, Bian X, Li L

Cancer Management and Research 2018, 10:23-32

Published Date: 3 January 2018

Radiotherapy for esophageal carcinoma: dose, response and survival

Luo Y, Mao Q, Wang X, Yu J, Li M

Cancer Management and Research 2018, 10:13-21

Published Date: 29 December 2017

Programmed death-ligand 1 expression correlates with diminished CD8+ T cell infiltration and predicts poor prognosis in anal squamous cell carcinoma patients

Zhao Y, Sun WP, Peng J, Deng Y, Fang Y, Huang J, Zhang H, Wan D, Lin J, Pan Z

Cancer Management and Research 2018, 10:1-11

Published Date: 18 December 2017

Clinical significance of miR-34a expression in thyroid diseases – an 18F-FDG PET-CT study

Chen L, Yang C, Feng J, Liu X, Tian Y, Zhao L, Xie R, Liu C, Zhao S, Sun H

Cancer Management and Research 2017, 9:903-913

Published Date: 15 December 2017

Expression profile analysis of long noncoding RNA in ER-positive subtype breast cancer using microarray technique and bioinformatics

Peng J, Zhang L, Yuan CW, Zhou LH, Xu SG, Lin YP, Zhang J, Yin WJ, Lu JS

Cancer Management and Research 2017, 9:891-901

Published Date: 14 December 2017

ZNF259 inhibits non-small cell lung cancer cells proliferation and invasion by FAK-AKT signaling

Shan Y, Cao W, Wang T, Jiang G, Zhang Y, Yang X

Cancer Management and Research 2017, 9:879-889

Published Date: 14 December 2017

Observation of different tumor motion magnitude within liver and estimate of internal motion margins in postoperative patients with hepatocellular carcinoma

Zhao YT, Liu ZK, Wu QW, Dai JR, Zhang T, Jia AY, Jin J, Wang SL, Li YX, Wang WH

Cancer Management and Research 2017, 9:839-848

Published Date: 12 December 2017

Prognostic role and clinical significance of trophoblast cell surface antigen 2 in various carcinomas

Xu P, Zhao Y, Liu K, Lin S, Liu X, Wang M, Yang P, Tian T, Zhu Y, Dai Z

Cancer Management and Research 2017, 9:821-837

Published Date: 12 December 2017

Comparison of survival outcomes between radical hysterectomy and definitive radiochemotherapy in stage IB1 and IIA1 cervical cancer

Wu SG, Zhang WW, He ZY, Sun JY, Wang Y, Zhou J

Cancer Management and Research 2017, 9:813-819

Published Date: 11 December 2017

The applications of liquid biopsy in resistance surveillance of anaplastic lymphoma kinase inhibitor

Chen Y, Guo W, Fan J, Chen Y, Zhang X, Chen X, Luo P

Cancer Management and Research 2017, 9:801-811

Published Date: 7 December 2017

Economic burden of the management of metastatic castrate-resistant prostate cancer in Italy: a cost of illness study

Restelli U, Ceresoli GL, Croce D, Evangelista L, Maffioli LS, Gianoncelli L, Bombardieri E

Cancer Management and Research 2017, 9:789-800

Published Date: 7 December 2017

Sites of metastasis and overall survival in esophageal cancer: a population-based study

Wu SG, Zhang WW, He ZY, Sun JY, Chen YX, Guo L

Cancer Management and Research 2017, 9:781-788

Published Date: 6 December 2017

Low expression of GATA3 promotes cell proliferation and metastasis in gastric cancer

Wei S, Zhong L, Wang X, Zhang W

Cancer Management and Research 2017, 9:769-780

Published Date: 7 December 2017

Can 18F-FDG PET predict the grade of malignancy in thymic epithelial tumors? An evaluation of only resected tumors

Nakagawa K, Takahashi S, Endo M, Ohde Y, Kurihara H, Terauchi T

Cancer Management and Research 2017, 9:761-768

Published Date: 5 December 2017

Prognostic value of Cox-2 and PD-L1 expression and its relationship with tumor-infiltrating lymphocytes in resected lung adenocarcinoma

Shimizu K, Okita R, Saisho S, Maeda A, Nojima Y, Nakata M

Cancer Management and Research 2017, 9:741-750

Published Date: 30 November 2017

The effect of medication nonadherence on progression-free survival among patients with renal cell carcinoma

Shafrin J, Sullivan J, Chou JW, Neely MN, Doan JF, Maclean JR

Cancer Management and Research 2017, 9:731-739

Published Date: 29 November 2017

The burden of selected cancers in the US: health behaviors and health care resource utilization

Iadeluca L, Mardekian J, Chander P, Hopps M, Makinson GT

Cancer Management and Research 2017, 9:721-730

Published Date: 28 November 2017

Selective serotonin reuptake inhibitors and the risk of hepatocellular carcinoma in hepatitis B virus-infected patients

Chang CM, Hsieh MS, Yang TC, Hsieh VC, Chiang JH, Huang HH, How CK, Hu SY, Yen DH

Cancer Management and Research 2017, 9:709-720

Published Date: 28 November 2017

Density of CD8+ lymphocytes in biopsy samples combined with the circulating lymphocyte ratio predicts pathologic complete response to chemoradiotherapy for rectal cancer

Xiao BY, Peng JH, Zhang RX, Xu J, Wang YC, Fang YJ, Lin JZ, Pan ZZ, Wu XJ

Cancer Management and Research 2017, 9:701-708

Published Date: 27 November 2017

Mesenchymal phenotype of circulating tumor cells is associated with distant metastasis in breast cancer patients

Zhang SR, Wu TC, Peng XG, Liu J, Liu F, Wu SY, Liu SY, Dong Y, Xie SJ, Ma SL

Cancer Management and Research 2017, 9:691-700

Published Date: 23 November 2017

Prognostic and clinicopathological value of Ki-67/MIB-1 expression in renal cell carcinoma: a meta-analysis based on 4579 individuals

Wang Z, Xie H, Guo LP, Cai QL, Shang ZQ, Jiang N, Niu YJ

Cancer Management and Research 2017, 9:679-689

Published Date: 21 November 2017

Efficacy and safety of pemetrexed and nedaplatin followed by pemetrexed maintenance therapy in advanced lung adenocarcinoma

Lin Z, Lv WZ, Wang SY, Zou JL, Con YY, Wang ZH, Xiao M, Peng PJ

Cancer Management and Research 2017, 9:671-677

Published Date: 20 November 2017

Enhanced recovery programs in lung cancer surgery: systematic review and meta-analysis of randomized controlled trials

Li S, Zhou K, Che G, Yang M, Su J, Shen C, Yu P

Cancer Management and Research 2017, 9:657-670

Published Date: 16 November 2017

Expression of minichromosome maintenance genes in renal cell carcinoma

Zhong HB, Chen B, Neves H, Xing JC, Ye YX, Lin Y, Zhuang GH, Zhang SD, Huang JY, Kwok HF

Cancer Management and Research 2017, 9:637-647

Published Date: 15 November 2017

Risk factors for hypocalcemia and hypoparathyroidism following thyroidectomy: a retrospective Chinese population study

Wang Y, Bhandari A, Yang F, Zhang W, Xue L, Liu H, Zhang X, Chen C

Cancer Management and Research 2017, 9:627-635

Published Date: 15 November 2017

Prognostic value of site-specific metastases and therapeutic roles of surgery for patients with metastatic bladder cancer: a population-based study

Dong F, Shen Y, Gao F, Xu T, Wang X, Zhang X, Zhong S, Zhang M, Chen S, Shen Z

Cancer Management and Research 2017, 9:611-626

Published Date: 14 November 2017

Training surgeons in shared decision-making with cancer patients aged 65 years and older: a pilot study

Geessink NH, Schoon Y, Olde Rikkert MGM, van Goor H

Cancer Management and Research 2017, 9:591-600

Published Date: 10 November 2017

Exome and transcriptome sequencing identifies loss of PDLIM2 in metastatic colorectal cancers

Oh BY, Cho J, Hong HK, Bae JS, Park WY, Joung JG, Cho YB

Cancer Management and Research 2017, 9:581-589

Published Date: 8 November 2017

Characteristics and prognostic factors of colorectal mucinous adenocarcinoma with signet ring cells

Kong XQ, Zhang XQ, Huang YX, Tang LR, Peng QQ, Li JL

Cancer Management and Research 2017, 9:573-580

Published Date: 2 November 2017

Nifuratel, a novel STAT3 inhibitor with potent activity against human gastric cancer cells

Zheng HL, Hong H, Zhang LL, Cai X, Hu M, Cai YP, Zhou B, Lin JY, Zhao CG, Hu WL

Cancer Management and Research 2017, 9:565-572

Published Date: 1 November 2017

Clinical aspects of foot health and their influence on quality of life among breast cancer survivors: a case–control study

Palomo-López P, Rodríguez-Sanz D, Becerro-de-Bengoa-Vallejo R, Losa-Iglesias ME, Guerrero-Martín J, Calvo-Lobo C, López-López D

Cancer Management and Research 2017, 9:545-551

Published Date: 1 November 2017

High expression of eIF3d is associated with poor prognosis in patients with gastric cancer

He JQ, Wang XF, Cai JH, Wang W, Qin XY

Cancer Management and Research 2017, 9:539-544

Published Date: 25 October 2017

Partial hepatectomy for spontaneous tumor rupture in patients with hepatocellular carcinoma: a retrospective cohort study

Zhu Q, Qiao G, Xu C, Guo D, Tang J, Duan R, Li Y

Cancer Management and Research 2017, 9:525-537

Published Date: 19 October 2017

Extrahepatic metastasis risk of hepatocellular carcinoma based on α-fetoprotein and tumor staging parameters at cross-sectional imaging

Yokoo T, Patel AD, Lev-Cohain N, Singal AG, Yopp AC, Pedrosa I

Cancer Management and Research 2017, 9:503-511

Published Date: 16 October 2017

Interleukin-1 receptor antagonist inhibits angiogenesis via blockage IL-1α/PI3K/NF-κB pathway in human colon cancer cell

Ma J, Sun X, Guo T, Su H, Chen Q, Gong Z, Qi J, Zhao X

Cancer Management and Research 2017, 9:481-493

Published Date: 9 October 2017

Surgical resection of a primary tumor improves survival of metastatic pancreatic cancer: a population-based study

Tao LY, Yuan CH, Ma ZL, Jiang B, Xiu DR

Cancer Management and Research 2017, 9:471-479

Published Date: 3 October 2017

Clinical implications of six inflammatory biomarkers as prognostic indicators in Ewing sarcoma

Li YJ, Yang X, Zhang WB, Yi C, Wang F, Li P

Cancer Management and Research 2017, 9:443-451

Published Date: 28 September 2017

Challenging the standard of care in advanced melanoma: focus on pembrolizumab

Abdul-Karim RM, Cowey CL

Cancer Management and Research 2017, 9:433-442

Published Date: 25 September 2017

Unintended target effect of anti-BCL-2 DNAi

Ebrahim AS, Kandouz M, Emara N, Sugalski AB, Lipovich L, Al-Katib AM

Cancer Management and Research 2017, 9:427-432

Published Date: 22 September 2017

A p53-regulated apoptotic gene signature predicts treatment response and outcome in pediatric acute lymphoblastic leukemia

Bainer RO, Trendowski MR, Cheng C, Pei D, Yang W, Paugh SW, Goss KH, Skol AD, Pavlidis P, Pui CH, Gilliam TC, Evans WE, Onel K

Cancer Management and Research 2017, 9:397-410

Published Date: 13 September 2017

Standard of care and direct medical costs of the treatment of chronic lymphocytic leukemia among the adult population in Ukraine, Russia, and Kazakhstan: data from the LEUKOSPECT study

Vasylyev A, Molostvova V, Rebrov BA, Makarova J, Zaritskey A, Ptushkin V, Ramazanova R, Popovych Y, Tsyapka O, Pashanov E

Cancer Management and Research 2017, 9:387-395

Published Date: 7 September 2017

SIRT1 gene polymorphisms and risk of lung cancer

Lv Y, Lin SY, Peng F

Cancer Management and Research 2017, 9:381-386

Published Date: 4 September 2017

Head and neck cancer: improving outcomes with a multidisciplinary approach

Lo Nigro C, Denaro N, Merlotti A, Merlano M

Cancer Management and Research 2017, 9:363-371

Published Date: 18 August 2017

Vaginal cuff brachytherapy in endometrial cancer – a technically easy treatment?

Sabater S, Andres I, Lopez-Honrubia V, Berenguer R, Sevillano M, Jimenez-Jimenez E, Rovirosa A, Arenas M

Cancer Management and Research 2017, 9:351-362

Published Date: 9 August 2017

Survivorship of patients with head and neck cancer receiving care in a tertiary health facility in Nigeria

Okwor VC, Fagbamigbe AF, Fawole OI

Cancer Management and Research 2017, 9:331-338

Published Date: 21 July 2017

Exploring the acceptability of human papillomavirus self-sampling among Muslim immigrant women

Lofters AK, Vahabi M, Fardad M, Raza A

Cancer Management and Research 2017, 9:323-329

Published Date: 19 July 2017

The impact of examined lymph node count on survival in squamous cell carcinoma and adenocarcinoma of the uterine cervix

Zhou J, Zhang WW, Wu SG, He ZY, Sun JY, Wang Y, Chen QH

Cancer Management and Research 2017, 9:315-322

Published Date: 18 July 2017

Emerging combination therapies for the management of multiple myeloma: the role of elotuzumab

Chen WC, Kanate AS, Craig M, Petros WP, Hazlehurst LA

Cancer Management and Research 2017, 9:307-314

Published Date: 12 July 2017

Estrogen-mediated hemangioma-derived stem cells through estrogen receptor-α for infantile hemangioma

Zhang L, Wu H, Yuan W, Zheng J

Cancer Management and Research 2017, 9:279-286

Published Date: 7 July 2017

What we know about surgical therapy in early-stage non-small-cell lung cancer: a guide for the medical oncologist

Ghanem S, El Bitar S, Hossri S, Weerasinghe C, Atallah JP

Cancer Management and Research 2017, 9:267-278

Published Date: 6 July 2017

Tumor cell PD-L1 predicts poor local control for rectal cancer patients following neoadjuvant radiotherapy

Shao LD, Peng QQ, Du KX, He JY, Dong YP, Lin XY, Li JL, Wu JX

Cancer Management and Research 2017, 9:249-258

Published Date: 29 June 2017

Management of malignant pleural effusion: challenges and solutions

Penz E, Watt KN, Hergott CA, Rahman NM, Psallidas I

Cancer Management and Research 2017, 9:229-241

Published Date: 23 June 2017

Chemotherapy-associated paronychia treated with 2% povidone–iodine: a series of cases

Capriotti K, Capriotti J, Pelletier J, Stewart K

Cancer Management and Research 2017, 9:225-228

Published Date: 26 June 2017

Emerging use of everolimus in the treatment of neuroendocrine tumors

Gajate P, Martínez-Sáez O, Alonso-Gordoa T, Grande E

Cancer Management and Research 2017, 9:215-224

Published Date: 20 June 2017

Clinical features, diagnostic challenges, and management strategies in checkpoint inhibitor-related pneumonitis

Chuzi S, Tavora F, Cruz M, Costa R, Chae YK, Carneiro BA, Giles FJ

Cancer Management and Research 2017, 9:207-213

Published Date: 14 June 2017

Can biosimilars help achieve the goals of US health care reform?

Boccia R, Jacobs I, Popovian R, de Lima Lopes Jr G

Cancer Management and Research 2017, 9:197-205

Published Date: 1 June 2017

Multiple myeloma in Niger Delta, Nigeria: complications and the outcome of palliative interventions

Nwabuko OC, Igbigbi EE, Chukwuonye II, Nnoli MA

Cancer Management and Research 2017, 9:189-196

Published Date: 22 May 2017

Considering renal risk while managing cancer

Shahinian VB, Bahl A, Niepel D, Lorusso V

Cancer Management and Research 2017, 9:167-178

Published Date: 16 May 2017

Patient and physician preferences for anticancer drugs for the treatment of metastatic colorectal cancer: a discrete-choice experiment

González JM, Ogale S, Morlock R, Posner J, Hauber B, Sommer N, Grothey A

Cancer Management and Research 2017, 9:149-158

Published Date: 27 April 2017

Symptomatic central nervous system involvement in adult patients with acute myeloid leukemia

Alakel N, Stölzel F, Mohr B, Kramer M, Oelschlägel U, Röllig C, Bornhäuser M, Ehninger G, Schaich M

Cancer Management and Research 2017, 9:97-102

Published Date: 29 March 2017

New developments in the management of Waldenström macroglobulinemia

Abeykoon JP, Yanamandra U, Kapoor P

Cancer Management and Research 2017, 9:73-83

Published Date: 10 March 2017

Glucocorticoid receptor expression in 20 solid tumor types using immunohistochemistry assay

Block TS, Murphy TI, Munster PN, Nguyen DP, Lynch FJ

Cancer Management and Research 2017, 9:65-72

Published Date: 6 March 2017

Update on the optimal use of bortezomib in the treatment of multiple myeloma

Mohan M, Matin A, Davies FE

Cancer Management and Research 2017, 9:51-63

Published Date: 2 March 2017

Feasibility of an exercise intervention for fatigued breast cancer patients at a community-based cardiac rehabilitation program

De Jesus S, Fitzgeorge L, Unsworth K, Massel D, Suskin N, Prapavessis H, Sanatani M

Cancer Management and Research 2017, 9:29-39

Published Date: 10 February 2017

Antioxidant activity of ginger extract as a daily supplement in cancer patients receiving adjuvant chemotherapy: a pilot study

Danwilai K, Konmun J, Sripanidkulchai B, Subongkot S

Cancer Management and Research 2017, 9:11-18

Published Date: 31 January 2017

Implantation of permanent pleural catheter for palliation of malignant pleural effusion

Meier M, Mortensen MR, Larsen LU

Cancer Management and Research 2016, 8:129-133

Published Date: 8 November 2016

Atypical teratoid/rhabdoid tumors: challenges and search for solutions

Biswas A, Kashyap L, Kakkar A, Sarkar C, Julka PK

Cancer Management and Research 2016, 8:115-125

Published Date: 16 September 2016

Advanced soft-tissue sarcoma and treatment options: critical appraisal of trabectedin

Desar IME, Constantinidou A, Kaal SEJ, Jones RL, van der Graaf WTA

Cancer Management and Research 2016, 8:95-104

Published Date: 17 August 2016

Treatment patterns, health state, and health care resource utilization of patients with radioactive iodine refractory differentiated thyroid cancer

Gianoukakis AG, Flores NM, Pelletier CL, Forsythe A, Wolfe GR, Taylor MH

Cancer Management and Research 2016, 8:67-76

Published Date: 30 May 2016

Novel approaches to target HER2-positive breast cancer: trastuzumab emtansine

Recondo G Jr, de la Vega M, Galanternik F, Díaz-Cantón E, Leone BA, Leone JP

Cancer Management and Research 2016, 8:57-65

Published Date: 19 May 2016

Multidisciplinary management for esophageal and gastric cancer

Boniface MM, Wani SB, Schefter TE, Koo PJ, Meguid C, Leong S, Kaplan JB, Wingrove LJ, McCarter MD

Cancer Management and Research 2016, 8:39-44

Published Date: 22 April 2016

Neoadjuvant therapy for early-stage breast cancer: the clinical utility of pertuzumab

Gollamudi J, Parvani JG, Schiemann WP, Vinayak S

Cancer Management and Research 2016, 8:21-31

Published Date: 18 February 2016

EGFR testing and clinical management of advanced NSCLC: a Galician Lung Cancer Group study (GGCP 048-10)

Vázquez S, Casal J, Afonso Afonso FJ, Fírvida JL, Santomé L, Barón F, Lázaro M, Pena C, Amenedo M, Abdulkader I, González-Arenas C, Fachal L, Vega A

Cancer Management and Research 2016, 8:11-20

Published Date: 4 February 2016

Hemoglobin levels and quality of life in patients with symptomatic chemotherapy-induced anemia: the eAQUA study

Mouysset JL, Freier B, van den Bosch J, Levaché CB, Bols A, Tessen HW, Belton L, Bohac GC, Terwey JH, Tonini G

Cancer Management and Research 2016, 8:1-10

Published Date: 21 January 2016

Durable response using regorafenib in an elderly patient with metastatic colorectal cancer: case report

Tang R, Kain T, Herman J, Seery T

Cancer Management and Research 2015, 7:357-360

Published Date: 19 November 2015

Clinical utility of RapidArcTM radiotherapy technology

Infusino E

Cancer Management and Research 2015, 7:345-356

Published Date: 12 November 2015

Critical appraisal of rituximab in the maintenance treatment of advanced follicular lymphoma

Aguiar-Bujanda D, Blanco-Sánchez MJ, Hernández-Sosa M, Galván-Ruíz S, Hernández-Sarmiento S

Cancer Management and Research 2015, 7:319-330

Published Date: 27 October 2015

Prospective noninterventional study on the use of panitumumab monotherapy in patients with recurrent or progressive colorectal cancer: the VECTIS study

Lakomy R, Rogowski W, Piko B, Mihaylova Zh, Pritzova E, Kvocekova L

Cancer Management and Research 2015, 7:311-318

Published Date: 23 October 2015

Targeting autophagy in cancer management – strategies and developments

Ozpolat B, Benbrook DM

Cancer Management and Research 2015, 7:291-299

Published Date: 11 September 2015

Cost-effectiveness of adding rituximab to fludarabine and cyclophosphamide for treatment of chronic lymphocytic leukemia in Ukraine

Mandrik O, Corro Ramos I, Knies S, Al M, Severens JL

Cancer Management and Research 2015, 7:279-289

Published Date: 25 August 2015

The treatment landscape in thyroid cancer: a focus on cabozantinib

Weitzman SP, Cabanillas ME

Cancer Management and Research 2015, 7:265-278

Published Date: 19 August 2015

Progress toward overcoming hypoxia-induced resistance to solid tumor therapy

Karakashev SV, Reginato MJ

Cancer Management and Research 2015, 7:253-264

Published Date: 12 August 2015

Potential of epigenetic therapies in the management of solid tumors

Valdespino V, Valdespino PM

Cancer Management and Research 2015, 7:241-251

Published Date: 31 July 2015

Clinical management of grade III oligodendroglioma

Simonetti G, Gaviani P, Botturi A, Innocenti A, Lamperti E, Silvani A

Cancer Management and Research 2015, 7:213-223

Published Date: 27 July 2015

Review of advanced catheter technologies in radiation oncology brachytherapy procedures

Zhou J, Zamdborg L, Sebastian E

Cancer Management and Research 2015, 7:199-211

Published Date: 16 July 2015

Treatment of metastatic colorectal cancer: focus on panitumumab

Tay RY, Wong R, Hawkes EA

Cancer Management and Research 2015, 7:189-198

Published Date: 24 June 2015

5-Fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) plus sunitinib or bevacizumab as first-line treatment for metastatic colorectal cancer: a randomized Phase IIb study

Hecht JR, Mitchell EP, Yoshino T, Welslau M, Lin X, Chow Maneval E, Paolini J, Lechuga MJ, Kretzschmar A

Cancer Management and Research 2015, 7:165-173

Published Date: 15 June 2015

A profile of enzalutamide for the treatment of advanced castration resistant prostate cancer

Greasley R, Khabazhaitajer M, Rosario DJ

Cancer Management and Research 2015, 7:153-164

Published Date: 12 June 2015

Cancer therapy and cardiovascular risk: focus on bevacizumab

Economopoulou P, Kotsakis A, Kapiris I, Kentepozidis N

Cancer Management and Research 2015, 7:133-143

Published Date: 3 June 2015

Expanding role of lenalidomide in hematologic malignancies

Ghosh N, Grunwald MR, Fasan O, Bhutani M

Cancer Management and Research 2015, 7:105-119

Published Date: 2 May 2015

Pharmacokinetics, safety, and efficacy of APF530 (extended-release granisetron) in patients receiving moderately or highly emetogenic chemotherapy: results of two Phase II trials

Gabrail N, Yanagihara R, Spaczyński M, Cooper W, O’Boyle E, Smith C, Boccia R

Cancer Management and Research 2015, 7:83-92

Published Date: 17 March 2015

Afatinib for the treatment of metastatic non-small cell lung cancer

Joshi M, Rizvi SM, Belani CP

Cancer Management and Research 2015, 7:75-82

Published Date: 19 February 2015

Evaluating the safety and efficacy of axitinib in the treatment of advanced renal cell carcinoma

Gunnarsson O, Pfanzelter NR, Cohen RB, Keefe SM

Cancer Management and Research 2015, 7:65-73

Published Date: 11 February 2015

Lung and colorectal cancer treatment and outcomes in the Veterans Affairs health care system

Zullig LL, Williams CD, Fortune-Britt AG

Cancer Management and Research 2015, 7:19-35

Published Date: 14 January 2015

Biliary stenting in advanced malignancy: an analysis of predictive factors for survival

Afshar M, Khanom K, Ma YT, Punia P

Cancer Management and Research 2014, 6:475-479

Published Date: 10 December 2014

Malignant phyllodes tumor of the breast presenting with hypoglycemia: a case report and literature review

Pacioles T, Seth R, Orellana C, John I, Panuganty V, Dhaliwal R

Cancer Management and Research 2014, 6:467-473

Published Date: 8 December 2014

Survival benefit of adjuvant radiotherapy in stage III and IV bladder cancer: results of 170 patients

Bayoumi Y, Heikal T, Darweish H

Cancer Management and Research 2014, 6:459-465

Published Date: 27 November 2014

Higher susceptibility of NOD/LtSz-scid Il2rg-/- NSG mice to xenotransplanted lung cancer cell lines

Kanaji N, Tadokoro A, Susaki K, Yokokura S, Ohmichi K, Haba R, Watanabe N, Bandoh S, Ishii T, Dobashi H, Matsunaga T

Cancer Management and Research 2014, 6:431-436

Published Date: 21 October 2014

MicroRNA dysregulation as a prognostic biomarker in colorectal cancer

Dong Y, Yu J, Ng SS

Cancer Management and Research 2014, 6:405-422

Published Date: 14 October 2014

The impact of bevacizumab treatment on survival and quality of life in newly diagnosed glioblastoma patients

Poulsen HS, Urup T, Michaelsen SR, Staberg M, Villingshøj M, Lassen U

Cancer Management and Research 2014, 6:373-387

Published Date: 26 September 2014

Interpreting overall survival results when progression-free survival benefits exist in today's oncology landscape: a metastatic renal cell carcinoma case study

Tang Y, Bycott P, Åkerborg Ö, Jönsson L, Negrier S, Chen C

Cancer Management and Research 2014, 6:365-371

Published Date: 22 September 2014

Treating advanced melanoma: current insights and opportunities

Tronnier M, Mitteldorf C

Cancer Management and Research 2014, 6:349-356

Published Date: 10 September 2014

Is extended-field concurrent chemoradiation an option for radiologic negative paraaortic lymph node, locally advanced cervical cancer?

Asiri MA, Tunio MA, Mohamed R, Bayoumi Y, Alhadab A, Saleh RM, AlArifi MS, Alobaid A

Cancer Management and Research 2014, 6:339-348

Published Date: 9 September 2014

Fertility preservation and GnRHa for chemotherapy: debate

Blumenfeld Z

Cancer Management and Research 2014, 6:313-315

Published Date: 19 August 2014

Computational prognostic indicators for breast cancer

Yang X, Ai X, Cunningham JM

Cancer Management and Research 2014, 6:301-312

Published Date: 12 July 2014

Prognostic stratification of colorectal cancer patients: current perspectives

Schneider NI, Langner C

Cancer Management and Research 2014, 6:291-300

Published Date: 2 July 2014

High plasma exposure to pemetrexed leads to severe hyponatremia in patients with advanced non small cell lung cancer receiving pemetrexed-platinum doublet chemotherapy

Gota V, Kavathiya K, Doshi K, Gurjar M, Damodaran SE, Noronha V, Joshi A, Prabhash K

Cancer Management and Research 2014, 6:261-265

Published Date: 4 June 2014

Future of bisphosphonates and denosumab for men with advanced prostate cancer

Iranikhah M, Stricker S, Freeman MK

Cancer Management and Research 2014, 6:217-224

Published Date: 3 May 2014

Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives

Díaz-López A, Moreno-Bueno G, Cano A

Cancer Management and Research 2014, 6:205-216

Published Date: 25 April 2014

Genetic factors and breast cancer laterality

Amer MH

Cancer Management and Research 2014, 6:191-203

Published Date: 16 April 2014

Chemotherapy-induced peripheral neuropathy in adults: a comprehensive update of the literature

Argyriou AA, Kyritsis AP, Makatsoris T, Kalofonos HP

Cancer Management and Research 2014, 6:135-147

Published Date: 19 March 2014

Multiple neoplasms, single primaries, and patient survival

Amer MH

Cancer Management and Research 2014, 6:119-134

Published Date: 5 March 2014

Fertility preservation during cancer treatment: clinical guidelines

Rodriguez-Wallberg KA, Oktay K

Cancer Management and Research 2014, 6:105-117

Published Date: 4 March 2014

DNA repair in cancer: emerging targets for personalized therapy

Abbotts R, Thompson N, Madhusudan S

Cancer Management and Research 2014, 6:77-92

Published Date: 19 February 2014

Daily baseline skin care in the prevention, treatment, and supportive care of skin toxicity in oncology patients: recommendations from a multinational expert panel

Bensadoun RJ, Humbert P, Krutman J, Luger T, Triller R, Rougier A, Seite S, Dreno B

Cancer Management and Research 2013, 5:401-408

Published Date: 9 December 2013

Personalized treatment for advanced colorectal cancer: KRAS and beyond

Patel GS, Karapetis CS

Cancer Management and Research 2013, 5:387-400

Published Date: 21 November 2013

Factors influencing choice of chemotherapy in metastatic colorectal cancer (mCRC)

Rossi L, Vakiarou F, Zoratto F, Bianchi L, Papa A, Basso E, Verrico M, Lo Russo G, Evangelista S, Rinaldi G, Perrone-Congedi F, Spinelli GP, Stati V, Caruso D, Prete A, Tomao S

Cancer Management and Research 2013, 5:377-385

Published Date: 19 November 2013

The claudin family of proteins in human malignancy: a clinical perspective

Ding L, Lu Z, Lu Q, Chen YH

Cancer Management and Research 2013, 5:367-375

Published Date: 8 November 2013

The prognostic value of ERCC1 and RRM1 gene expression in completely resected non-small cell lung cancer: tumor recurrence and overall survival

Tantraworasin A, Saeteng S, Lertprasertsuke N, Arayawudhikul N, Kasemsarn C, Patumanond J

Cancer Management and Research 2013, 5:327-336

Published Date: 3 October 2013

Focal low-dose rate brachytherapy for the treatment of prostate cancer

Tong WY, Cohen G, Yamada Y

Cancer Management and Research 2013, 5:315-325

Published Date: 13 September 2013

Critical appraisal of the potential use of cannabinoids in cancer management

Cridge BJ, Rosengren RJ

Cancer Management and Research 2013, 5:301-313

Published Date: 30 August 2013

Perspectives on the immunologic microenvironment of astrocytomas

Hewedi IH, Radwan NA, Shash LS, Elserry TH

Cancer Management and Research 2013, 5:293-299

Published Date: 30 August 2013

AKT-independent PI3-K signaling in cancer – emerging role for SGK3

Bruhn MA, Pearson RB, Hannan RD, Sheppard KE

Cancer Management and Research 2013, 5:281-292

Published Date: 26 August 2013

Targeting CD19 in B-cell lymphoma: emerging role of SAR3419

Raufi A, Ebrahim AS, Al-Katib A

Cancer Management and Research 2013, 5:225-233

Published Date: 27 August 2013

Anemia prevalence and treatment practice in patients with non-myeloid tumors receiving chemotherapy

Merlini L, Cartenì G, Iacobelli S, Stelitano C, Airoldi M, Balcke P, Keil F, Haslbauer F, Belton L, Pujol B

Cancer Management and Research 2013, 5:205-214

Published Date: 2 August 2013

Cancer-associated thrombosis: clinical presentation and survival

Amer MH

Cancer Management and Research 2013, 5:165-178

Published Date: 26 July 2013

The association of race with timeliness of care and survival among Veterans Affairs health care system patients with late-stage non-small cell lung cancer

Zullig LL, Carpenter WR, Provenzale DT, Weinberger M, Reeve BB, Williams CD, Jackson GL

Cancer Management and Research 2013, 5:157-163

Published Date: 24 July 2013

New and emerging combination therapies for esophageal cancer

Wiedmann MW, Mössner J

Cancer Management and Research 2013, 5:133-146

Published Date: 27 June 2013

Serous endometrial intraepithelial carcinoma: a case series and literature review

Pathiraja P, Dhar S, Haldar K

Cancer Management and Research 2013, 5:117-122

Published Date: 17 June 2013

Clinical outcome of incidentally discovered small renal cell carcinoma after delayed surgery

Sugimoto K, Shimizu N, Oki T, Nose K, Nishioka T, Adomi S, Ohzeki T, Esa A, Uemura H

Cancer Management and Research 2013, 5:85-89

Published Date: 24 May 2013

Prognostic factors of tumor recurrence in completely resected non-small cell lung cancer

Tantraworasin A, Seateang S, Lertprasertsuke N, Arreyakajohn N, Kasemsarn C, Patumanond J

Cancer Management and Research 2013, 5:77-84

Published Date: 6 June 2013

Nedaplatin: a cisplatin derivative in cancer chemotherapy

Shimada M, Itamochi H, Kigawa J

Cancer Management and Research 2013, 5:67-76

Published Date: 8 May 2013

Advanced medullary thyroid cancer: pathophysiology and management

Ferreira CV, Siqueira DR, Ceolin L, Maia AL

Cancer Management and Research 2013, 5:57-66

Published Date: 8 May 2013

Critical appraisal of the use of regorafenib in the management of colorectal cancer

Festino L, Fabozzi A, Manzo A, Gambardella V, Martinelli E, Troiani T, De Vita F, Orditura M, Ciardiello F, Morgillo F

Cancer Management and Research 2013, 5:49-55

Published Date: 12 April 2013

Economic evaluation of therapies for patients suffering from relapsed-refractory multiple myeloma in Greece

Fragoulakis V, Kastritis E, Psaltopoulou T, Maniadakis N

Cancer Management and Research 2013, 5:37-48

Published Date: 10 April 2013

Gastric cancer in young people under 30 years of age: worse prognosis, or delay in diagnosis?

Lopez-Basave HN, Morales-Vasquez F, Ruiz-Molina JM, Namendys-Silva SA, Vela-Sarmiento I, Ruan JM, Padilla Rosciano AE, Calderillo-Ruiz G, Diaz-Romero C, Herrera-Gomez A, Meneses-Garcia AA

Cancer Management and Research 2013, 5:31-36

Published Date: 4 April 2013

Endoscopic endonasal approach for the treatment of a large clival giant cell tumor complicated by an intraoperative internal carotid artery rupture

Iacoangeli M, Di Rienzo A, Re M, Alvaro L, Nocchi N, Gladi M, De Nicola M, Scerrati M

Cancer Management and Research 2013, 5:21-24

Published Date: 30 January 2013

Clinical factors related to long-term administration of sorafenib in patients with hepatocellular carcinoma

Nojiri S, Kusakabe A, Fujiwara K, Shinkai N, Matsuura K, Iio E, Miyaki T, Nomura T, Sobue S, Sano H, Hasegawa I, Ohno T, Takahashi Y, Orito E, Joh T

Cancer Management and Research 2012, 4:423-429

Published Date: 18 December 2012

Intraperitoneal chemotherapy in ovarian cancer: a review of tolerance and efficacy

Chan DL, Morris DL, Rao A, Chua TC

Cancer Management and Research 2012, 4:413-422

Published Date: 23 November 2012

New drugs and combinations for the treatment of soft-tissue sarcoma: a review

Somaiah N, von Mehren M

Cancer Management and Research 2012, 4:397-411

Published Date: 23 November 2012

Carmustine enhances the anticancer activity of selenite in androgen-independent prostate cancer cells

Thamilselvan V, Menon M, Thamilselvan S

Cancer Management and Research 2012, 4:383-395

Published Date: 9 November 2012

Breast imaging reports for malignant lesions: are we maintaining recommended BI-RADS® lexicon standards?

Masroor I, Azeemuddin M, Sakhawat S, Beg M, Sohail S, Ahmed R, Ul-Haq I, Mehboob J

Cancer Management and Research 2012, 4:379-382

Published Date: 7 November 2012

Current treatment options for the management of esophageal cancer

Mawhinney MR, Glasgow RE

Cancer Management and Research 2012, 4:367-377

Published Date: 2 November 2012

Autophagy as a target for cancer therapy: new developments

Carew JS, Kelly KR, Nawrocki ST

Cancer Management and Research 2012, 4:357-365

Published Date: 11 October 2012

Pelvic exenteration for colorectal cancer: oncologic outcome in 59 patients at a single institution

López-Basave HN, Morales-Vásquez F, Herrera-Gómez Á, Padilla Rosciano A, Meneses-Garcíá A, Ruiz-Molina JM

Cancer Management and Research 2012, 4:351-356

Published Date: 11 October 2012

The effect of CyberKnife therapy on pulmonary function tests used for treating non-small cell lung cancer: a retrospective, observational cohort pilot study

Agarwal R, Saluja P, Pham A, Ledbetter K, Bains S, Varghese S, Clements J, Kim YH

Cancer Management and Research 2012, 4:347-350

Published Date: 10 October 2012

Effect of vaccination with N-glycolyl GM3/VSSP vaccine by subcutaneous injection in patients with advanced cutaneous melanoma

Osorio M, Gracia E, Reigosa E, Hernandez J, de la Torre A, Saurez G, Perez K, Viada C, Cepeda M, Carr A, Ávila Y, Rodríguez M, Fernandez LE

Cancer Management and Research 2012, 4:341-345

Published Date: 5 October 2012

Patient perception of disease control and psychological distress

Mazzotti E, Sebastiani C, Marchetti P

Cancer Management and Research 2012, 4:335-340

Published Date: 27 September 2012

Monocyte galactose/N-acetylgalactosamine-specific C-type lectin receptor stimulant immunotherapy of an experimental glioma. Part II: combination with external radiation improves survival

Kushchayev SV, Sankar T, Eggink LL, Kushchayeva YS, Wiener PC, Hoober JK, Eschbacher J, Liu R, Shi FD, Abdelwahab MG, Scheck AC, Preul MC

Cancer Management and Research 2012, 4:325-334

Published Date: 17 September 2012

Monocyte galactose/N-acetylgalactosamine-specific C-type lectin receptor stimulant immunotherapy of an experimental glioma. Part 1: stimulatory effects on blood monocytes and monocyte-derived cells of the brain

Kushchayev SV, Sankar T, Eggink LL, Kushchayeva YS, Wiener PC, Hoober JK, Eschbacher J, Liu R, Shi FD, Abdelwahab MG, Scheck AC, Preul MC

Cancer Management and Research 2012, 4:309-323

Published Date: 17 September 2012

Effects of Acanthus ebracteatus Vahl on tumor angiogenesis and on tumor growth in nude mice implanted with cervical cancer

Mahasiripanth T, Hokputsa S, Niruthisard S, Bhattarakosol P, Patumraj S

Cancer Management and Research 2012, 4:269-279

Published Date: 23 August 2012

Lenalidomide for the treatment of relapsed and refractory multiple myeloma

van de Donk NW, Görgün G, Groen RW, Jakubikova J, Mitsiades CS, Hideshima T, Laubach J, Nijhof IS, Raymakers RA, Lokhorst HM, Richardson PG, Anderson KC

Cancer Management and Research 2012, 4:253-268

Published Date: 14 August 2012

Vemurafenib: a new treatment for BRAF-V600 mutated advanced melanoma

Fisher R, Larkin J

Cancer Management and Research 2012, 4:243-252

Published Date: 8 August 2012

Retinoids in the treatment of glioma: a new perspective

Mawson AR

Cancer Management and Research 2012, 4:233-241

Published Date: 7 August 2012

Occupational exposure to wood dust and formaldehyde and risk of nasal, nasopharyngeal, and lung cancer among Finnish men

Siew SS, Kauppinen T, Kyyrönen P, Heikkila P, Pukkala E

Cancer Management and Research 2012, 4:223-232

Published Date: 7 August 2012

The bradykinin B2 receptor induces multiple cellular responses leading to the proliferation of human renal carcinoma cell lines

Kramarenko II, Morinelli TA, Bunni MA, Raymond JR Sr, Garnovskaya MN

Cancer Management and Research 2012, 4:195-205

Published Date: 26 July 2012

Update on the management of invasive bladder cancer 2012

Goethuys H, Van Poppel H

Cancer Management and Research 2012, 4:177-182

Published Date: 18 July 2012

Nodal involvement pattern in resectable lung cancer according to tumor location

Saeteng S, Tantraworasin A, Euathrongchit J, Lertprasertsuke N, Wannasopha Y

Cancer Management and Research 2012, 4:151-158

Published Date: 7 June 2012

Axillary dissection in primary breast cancer: variations of the surgical technique and influence on morbidity

Wojcinski S, Nuengsri S, Hillemanns P, Schmidt W, Deryal M, Ertan K, Degenhardt F

Cancer Management and Research 2012, 4:121-127

Published Date: 27 April 2012

Economic comparison of capecitabine + oxaliplatin and 5-fluorouracil + oxaliplatin in the adjuvant treatment of colon cancer

Aitini E, Rossi A, Morselli P, Vivorio B, Bruschi A, Bottura C, Colombo GL.

Cancer Management and Research 2012, 4:99-103

Published Date: 27 March 2012

Bevacizumab for the treatment of nonsquamous non-small-cell lung cancer in Portugal: a retrospective, multicenter study

Estevinho F, Soares M, Azevedo I, Queiroga H, Parente B, Brito U, Teixeira E, Sotto-Mayor R, Araújo A

Cancer Management and Research 2012, 4:91-97

Published Date: 13 March 2012

Management of cutaneous T cell lymphoma: new and emerging targets and treatment options

Li JY, Horwitz S, Moskowitz A, Myskowski PL, Pulitzer M, Querfeld C

Cancer Management and Research 2012, 4:75-89

Published Date: 12 March 2012

Psychological and sexual disorders in long-term breast cancer survivors

Pumo V , Milone G, Iacono M, Rametta Giuliano S, Di Mari A, Lopiano C, Bordonaro S, Tralongo P

Cancer Management and Research 2012, 4:61-65

Published Date: 24 February 2012

C-type lectin receptors and RIG-I-like receptors: new points on the oncogenomics map

Kutikhin AG, Yuzhalin AE

Cancer Management and Research 2012, 4:39-53

Published Date: 24 February 2012

Inherited variation in pattern recognition receptors and cancer: dangerous liaisons?

Kutikhin AG, Yuzhalin AE

Cancer Management and Research 2012, 4:31-38

Published Date: 16 February 2012

Are Toll-like receptor gene polymorphisms associated with prostate cancer?

Kutikhin AG, Yuzhalin AE

Cancer Management and Research 2012, 4:23-29

Published Date: 7 February 2012

Erratum

Krikeli M, Ekonomopoulou MT, Tzitzikas I, Goutzioulis A, Mystakidou K, Pistevou-Gompaki K

Cancer Management and Research 2011, 3:319-320

Published Date: 5 December 2011

Patient–provider communication data: linking process and outcomes in oncology care

Kennedy Sheldon L, Hong F, Berry DL

Cancer Management and Research 2011, 3:311-317

Published Date: 18 November 2011

Effects of CXCR4 siRNA/dextran-spermine nanoparticles on CXCR4 expression and serum LDH levels in a mouse model of colorectal cancer metastasis to the liver

Abedini F, Ismail M, Hosseinkhani H, Tengku Ibrahim TA, Omar AR, Chong PP, Hair Bejo M, Domb AJ

Cancer Management and Research 2011, 3:301-309

Published Date: 9 September 2011

Use of capecitabine in management of early colon cancer

Hameed H, Cassidy J

Cancer Management and Research 2011, 3:295-299

Published Date: 19 August 2011

Prophylactic cranial irradiation in non-small cell lung cancer patients: who might be the candidates?

Dimitropoulos C, Hillas G, Nikolakopoulou S, Kostara K, Sagris K, Vlastos F, Alchanatis M

Cancer Management and Research 2011, 3:287-294

Published Date: 17 August 2011

Use of neutral plasma coagulation in groin node dissection for vulvar malignancy: a novel technique

Madhuri TK, Tailor A, Butler-Manuel S

Cancer Management and Research 2011, 3:253-255

Published Date: 6 July 2011

Comparison of the impact of radiotherapy and radiochemotherapy on the quality of life of 1-year survivors with cervical cancer

Krikeli M, Ekonomopoulou MT, Tzitzikas I, Goutzioulis A, Mystakidou K, Pistevou-Gompaki K

Cancer Management and Research 2011, 3:247-251

Published Date: 6 July 2011

Clinical relevance and treatment of nonautoimmune anemia in chronic lymphocytic leukemia

Molica S, Mirabelli R, Molica M, Levato L, Mauro F, Foà R

Cancer Management and Research 2011, 3:211-217

Published Date: 1 June 2011

Dose study of the multikinase inhibitor, LY2457546, in patients with relapsed acute myeloid leukemia to assess safety, pharmacokinetics, and pharmacodynamics

Wacheck V, Lahn M, Dickinson G, Füreder W, Meyer R, Herndlhofer S, Füreder T, Dorfner G, Pillay S, André V, Burkholder TP, Akunda JK, Flye-Blakemore L, Van Bockstaele D, Schlenk RF, Sperr W, Valent P

Cancer Management and Research 2011, 3:157-175

Published Date: 10 May 2011

Interpreting clinical assays for histone deacetylase inhibitors

Martinet N, Bertrand P

Cancer Management and Research 2011, 3:117-141

Published Date: 9 May 2011

Improving evaluation of the distribution and density of immunostained cells in breast cancer using computerized video image analysis

Coventry BJ, Weightman MJ, Skinner JM, Bradley J

Cancer Management and Research 2011, 3:101-108

Published Date: 18 April 2011

Chemoprevention of prostate cancer with nutrients and supplements

Van Poppel H, Tombal B

Cancer Management and Research 2011, 3:91-100

Published Date: 6 April 2011

Capecitabine in the management of colorectal cancer

Hirsch BR, Zafar SY

Cancer Management and Research 2011, 3:79-89

Published Date: 24 March 2011

Critical appraisal of nilotinib in frontline treatment of chronic myeloid leukemia

David L DeRemer, Katerina Katsanevas, Celalettin Ustun

Cancer Management and Research 2011, 3:65-78

Published Date: 10 March 2011

Critical appraisal of trastuzumab in treatment of advanced stomach cancer

Judith Meza-Junco, Heather-Jane Au, Michael B Sawyer

Cancer Management and Research 2011, 3:57-64

Published Date: 3 March 2011

Cardiovascular risk during hormonal treatment in patients with prostate cancer

Hein Van Poppel, Bertrand Tombal

Cancer Management and Research 2011, 3:49-55

Published Date: 2 March 2011

Kefir induces cell-cycle arrest and apoptosis in HTLV-1-negative malignant T-lymphocytes

Katia Maalouf, Elias Baydoun, Sandra Rizk

Cancer Management and Research 2011, 3:39-47

Published Date: 14 February 2011

Targeted treatment of recurrent platinum-resistant ovarian cancer: current and emerging therapies

Gina M Mantia-Smaldone, Robert P Edwards, Anda M Vlad

Cancer Management and Research 2011, 3:25-38

Published Date: 30 December 2010

Colonic polyps: inheritance, susceptibility, risk evaluation, and diagnostic management

Emanuele Neri, Lorenzo Faggioni, Lorenzo Cini, et al

Cancer Management and Research 2011, 3:17-24

Published Date: 30 December 2010

From antiangiogenesis to hypoxia: current research and future directions

Christopher Rice, L Eric Huang

Cancer Management and Research 2011, 3:9-16

Published Date: 20 December 2010

Reduced cancer risk in vegetarians: an analysis of recent reports

Amy Joy Lanou, Barbara Svenson

Cancer Management and Research 2011, 3:1-8

Published Date: 20 December 2010

Cancer chemotherapy: targeting folic acid synthesis

Nicole Hagner, Markus Joerger

Cancer Management and Research 2010, 2:293-301

Published Date: 19 November 2010

The disparity of health facilities in an urban area discourages proposed treatment application in inoperable lung cancer patients

Georgios Hillas, Petros Bakakos, Miltiadis Trichas, et al

Cancer Management and Research 2010, 2:287-291

Published Date: 15 November 2010

Review of catumaxomab in the treatment of malignant ascites

Martin Sebastian

Cancer Management and Research 2010, 2:283-286

Published Date: 8 November 2010

The potential carcinogenic risk of tanning beds: clinical guidelines and patient safety advice

Mette Mogensen, Gregor BE Jemec

Cancer Management and Research 2010, 2:277-282

Published Date: 28 October 2010

FACE: the barefaced facts of AI potency

Alain Monnier

Cancer Management and Research 2010, 2:267-276

Published Date: 27 October 2010

Epigenomics in cancer management

Fabricio F Costa

Cancer Management and Research 2010, 2:255-265

Published Date: 27 October 2010

Radiotherapy combined with hormonal therapy in prostate cancer: the state of the art

Piotr Milecki, Piotr Martenka, Andrzej Antczak, et al

Cancer Management and Research 2010, 2:243-253

Published Date: 11 October 2010

New developments in treatment of ovarian carcinoma: focus on trabectedin

Philippe A Cassier, Aude Duret, Olivier Trédan, et al

Cancer Management and Research 2010, 2:233-242

Published Date: 1 October 2010

Frequency of heterozygous TET2 deletions in myeloproliferative neoplasms

Joseph Tripodi, Ronald Hoffman, Vesna Najfeld, et al

Cancer Management and Research 2010, 2:219-223

Published Date: 17 September 2010

Treatment of cutaneous melanoma: current approaches and future prospects

Alain P Algazi, Christopher W Soon, Adil I Daud

Cancer Management and Research 2010, 2:197-211

Published Date: 17 August 2010

Efficacy and safety of amrubicin hydrochloride for treatment of relapsed small cell lung cancer

Daiki Ogawara, Minoru Fukuda, Yoichi Nakamura, et al

Cancer Management and Research 2010, 2:191-195

Published Date: 11 August 2010

Cetuximab in the treatment of head and neck cancer: preliminary results outside clinical trials

Didier Dequanter, Mohammad Shahla, Pascal Paulus, et al

Cancer Management and Research 2010, 2:165-168

Published Date: 28 June 2010

Role of erlotinib in first-line and maintenance treatment of advanced non-small-cell lung cancer

Noemí Reguart, Andrés Felipe Cardona, Rafael Rosell

Cancer Management and Research 2010, 2:143-156

Published Date: 1 June 2010

Management of metastatic renal cell carcinoma in patients with poor prognosis

Andrea Bullock, David F McDermott, Michael B Atkins

Cancer Management and Research 2010, 2:123-132

Published Date: 24 May 2010

Global cancer research initiative

Richard R Love

Cancer Management and Research 2010, 2:105-109

Published Date: 3 May 2010

Role of bevacizumab therapy in the management of glioblastoma

Scott J Peak, Victor A Levin

Cancer Management and Research 2010, 2:97-104

Published Date: 22 April 2010

Rituximab for the treatment of patients with chronic lymphocytic leukemia

M Gentile, E Vigna, C Mazzone, et al

Cancer Management and Research 2010, 2:71-81

Published Date: 11 March 2010

Everolimus – a new approach in the treatment of renal cell carcinoma

G Anandappa, AE Hollingdale, TG Eisen

Cancer Management and Research 2010, 2:61-70

Published Date: 9 March 2010

Role of denileukin diftitox in the treatment of persistent or recurrent cutaneous T-cell lymphoma

Frederick Lansigan, Diane M Stearns, Francine Foss

Cancer Management and Research 2010, 2:53-59

Published Date: 5 February 2010

Evaluation of degarelix in the management of prostate cancer

Hendrik Van Poppel

Cancer Management and Research 2010, 2:39-52

Published Date: 25 January 2010

Optimal management of cancer anorexia–cachexia syndrome

Josep M Argilés, Mireia Olivan, Sílvia Busquets, et al

Cancer Management and Research 2010, 2:27-38

Published Date: 22 January 2010

Role of lapatinib in the first-line treatment of patients with metastatic breast cancer

Catherine Oakman, Marta Pestrin, Elena Zafarana, et al

Cancer Management and Research 2010, 2:13-25

Published Date: 7 January 2010

The role of bendamustine in the treatment of indolent non-Hodgkin lymphoma

Ibrahim T Aldoss, Susan M Blumel, Philip J Bierman

Cancer Management and Research 2009, 1:155-165

Published Date: 12 November 2009

Critical appraisal of temozolomide formulations in the treatment of primary brain tumors: patient considerations

Margarita García, Ana Clopés, Jordi Bruna

Cancer Management and Research 2009, 1:137-150

Published Date: 30 October 2009

The role of azacitidine in the management of myelodysplastic syndromes (MDS)

KS Götze, C Müller-Thomas, C Peschel

Cancer Management and Research 2009, 1:119-130

Published Date: 9 October 2009

Bortezomib in the management of multiple myeloma

Jacob P Laubach, Constantine S Mitsiades, Teru Hideshima, et al

Cancer Management and Research 2009, 1:107-117

Published Date: 8 September 2009

Prevention of acute chemotherapy-induced nausea and vomiting: the role of palonosetron

Emilio Bajetta, Sara Pusceddu, Valentina Guadalupi, et al

Cancer Management and Research 2009, 1:89-97

Published Date: 10 August 2009

Evolving role of cetuximab in the treatment of colorectal cancer

Gunter Schuch, Sebastian Kobold, Carsten Bokemeyer

Cancer Management and Research 2009, 1:79-88

Published Date: 23 July 2009

Is social support associated with improved clinical outcomes in geriatric lung cancer patients? Observations from North Central Cancer Treatment Group Studies N9921 and N0222

Aminah Jatoi, Shauna L Hillman, Katie L Allen Ziegler, Philip J Stella, et al.

Cancer Management and Research 2009, 1:61-68

Published Date: 17 June 2009

Patient-derived acute myeloid leukemia (AML) bone marrow cells display distinct intracellular kinase phosphorylation patterns

Keith Shults, Leanne Flye, Lisa Green, Thomas Daly, et al.

Cancer Management and Research 2009, 1:49-59

Published Date: 15 May 2009

Validation of the cell cycle G2 delay assay in assessing ionizing radiation sensitivity and breast cancer risk

Jeff W Hill, Kristina Tansavatdi, Kristin L Lockett, Glenn O Allen, et al.

Cancer Management and Research 2009, 1:39-48

Published Date: 30 April 2009

Results of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer

Anthony V Nguyen, Micaela Martinez, Michael J Stamos, Mary P Moyer, Kestutis Planutis, Christopher Hope, Randall F Holcombe

Cancer Management and Research 2009, 1:25-37

Published Date: 3 April 2009

TGFβ signaling supports survival and metastasis of endometrial cancer cells

XiuFen Lei, Long Wang, Junhua Yang, Lu-Zhe Sun

Cancer Management and Research 2009, 1:15-24

Published Date: 1 April 2009